var title_f42_11_43184="Perinephric abscess CT";
var content_f42_11_43184=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Perinephric abscess on computed tomography scan",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 369px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Computed tomographic scan shows a large perinephric phlegmon with loculation adjacent to the right kidney.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Olivier Helenon, MD, Hopital Necker, Paris.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43184=[""].join("\n");
var outline_f42_11_43184=null;
var title_f42_11_43185="Patient information: Taking care of cuts and scrapes (The Basics)";
var content_f42_11_43185=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16585\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/63/29684\">",
"         Minor cuts and scrapes",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/32/28161\">",
"         Patient information: Animal bites (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?6/51/6962\">",
"         Patient information: Stitches (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?41/10/42145\">",
"         Patient information: Taking care of bruises (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?22/15/22770\">",
"         Patient information: Animal bites (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Taking care of cuts and scrapes (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/taking-care-of-cuts-and-scrapes-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H11043530\">",
"      <span class=\"h1\">",
"       Does my cut need stitches?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your cut does not go all the way through the skin, it does not need stitches (",
"      <a class=\"graphic graphic_figure graphicRef71752 \" href=\"mobipreview.htm?28/63/29684\">",
"       figure 1",
"      </a>",
"      ). If your cut is wide, jagged, or does go all the way through the skin, you will most likely need stitches. If you are unsure if your cut needs stitches, check with your doctor or nurse.",
"     </p>",
"     <p>",
"      This article discusses cuts and scrapes that do not need stitches. For information on stitches, see the following topic: (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/51/6962?source=see_link\">",
"       \"Patient information: Stitches (The Basics)\"",
"      </a>",
"      ).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11043545\">",
"      <span class=\"h1\">",
"       How do I take care of a cut or scrape on my own?",
"      </span>",
"      &nbsp;&mdash;&nbsp;To take care of your cut or scrape, follow these basic first aid guidelines:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Clean the cut or scrape &ndash; Wash it well with soap and water. If there is dirt, glass, or another object in your cut that you can&rsquo;t get out after you wash it, call your doctor or nurse.",
"       </li>",
"       <li>",
"        Stop the bleeding &ndash; If your cut or scrape is bleeding, press a clean cloth or bandage firmly on the area for 20 minutes. You can also help slow the bleeding by holding the cut above the level of your heart. If the bleeding doesn&rsquo;t stop after 20 minutes, call your doctor or nurse.",
"       </li>",
"       <li>",
"        Put a thin layer of antibiotic ointment on the cut or scrape.",
"       </li>",
"       <li>",
"        Cover the cut or scrape with a bandage or gauze. Keep the bandage clean and dry. Change the bandage 1 to 2 times every day until your cut or scrape heals.",
"       </li>",
"       <li>",
"        Watch for signs that your cut or scrape is infected (see below).",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Most cuts and scrapes heal on their own within 7 to 10 days. As your cut or scrape heals, a scab will form. Be sure to leave the scab alone and not pick at it.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11043560\">",
"      <span class=\"h1\">",
"       When should I call the doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Call the doctor or nurse if you have any signs of an infection. Signs of an infection include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Redness, swelling, warmth, or increased pain around the cut or scrape",
"       </li>",
"       <li>",
"        Pus draining from the cut or scrape",
"       </li>",
"       <li>",
"        Red streaks on the skin around the cut or scrape",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Cuts called &ldquo;puncture wounds&rdquo; have a higher chance of getting infected. A puncture wound is a type of cut that is made when a sharp object goes through the skin and into the tissue underneath.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11043575\">",
"      <span class=\"h1\">",
"       Will I need a tetanus shot?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Maybe. It depends on how old you are and when your last tetanus shot was. Tetanus is a serious infection that can cause muscle stiffness and spasms. It is caused by bacteria (germs) that live in the dirt.",
"     </p>",
"     <p>",
"      Most children get a tetanus vaccine as part of their routine check-ups. Vaccines are treatments (usually shots) that can prevent certain serious or deadly infections. Many adults also get a tetanus vaccine as part of their routine check-ups.",
"     </p>",
"     <p>",
"      If your skin is cut, and especially if the cut is dirty or deep, ask your doctor or nurse if you need a tetanus shot.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11043590\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/51/6962?source=see_link\">",
"       Patient information: Stitches (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?41/10/42145?source=see_link\">",
"       Patient information: Taking care of bruises (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/32/28161?source=see_link\">",
"       Patient information: Animal bites (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/15/22770?source=see_link\">",
"       Patient information: Animal bites (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?42/11/43185?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16585 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-259ED97FEC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43185=[""].join("\n");
var outline_f42_11_43185=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11043530\">",
"      Does my cut need stitches?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11043545\">",
"      How do I take care of a cut or scrape on my own?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11043560\">",
"      When should I call the doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11043575\">",
"      Will I need a tetanus shot?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11043590\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16585\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/63/29684\">",
"      Minor cuts and scrapes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/15/22770?source=related_link\">",
"      Patient information: Animal bites (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/32/28161?source=related_link\">",
"      Patient information: Animal bites (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/51/6962?source=related_link\">",
"      Patient information: Stitches (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?41/10/42145?source=related_link\">",
"      Patient information: Taking care of bruises (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_11_43186="Patient information: Breathing tests (The Basics)";
var content_f42_11_43186=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"11\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/85379\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/61/981\">",
"         Spirometry (breathing test)",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?4/11/4275\">",
"         Patient information: Asthma in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?16/58/17315\">",
"         Patient information: Asthma in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?14/48/15107\">",
"         Patient information: Chronic bronchitis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?4/59/5043\">",
"         Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?42/0/43011\">",
"         Patient information: Cough in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?13/7/13427\">",
"         Patient information: Cough in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?29/43/30386\">",
"         Patient information: Inhalers (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?6/46/6883\">",
"         Patient information: Shortness of breath (dyspnea) (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/34/28195\">",
"         Patient information: Chronic cough in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?1/13/1236\">",
"         Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Breathing tests (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/breathing-tests-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H260645207\">",
"      <span class=\"h1\">",
"       What are breathing tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Breathing tests are a group of tests that measure how well your lungs are working. The terms doctors use for these tests are &ldquo;pulmonary function tests&rdquo; or &ldquo;PFTs.&rdquo; Specifically, breathing tests measure:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        How much air you can breathe in and out of your lungs",
"       </li>",
"       <li>",
"        How fast you can breathe the air out of your lungs",
"       </li>",
"       <li>",
"        How much oxygen gets into your blood from your lungs",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H260645222\">",
"      <span class=\"h1\">",
"       Why might my doctor order breathing tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor might order breathing tests to:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Find the cause of symptoms such as a long-term cough, noisy breathing (wheezing), or trouble breathing",
"       </li>",
"       <li>",
"        Check if a known lung condition is mild or severe, or changes over time &ndash; Lung conditions that are commonly followed with breathing tests include asthma, chronic bronchitis, pulmonary fibrosis, and chronic obstructive pulmonary disease (also called &ldquo;COPD&rdquo;).",
"       </li>",
"       <li>",
"        Check how well your inhaler medicines are working",
"       </li>",
"       <li>",
"        Check how well your lungs are working before you have surgery",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H260645237\">",
"      <span class=\"h1\">",
"       How do I prepare for breathing tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or nurse will tell you if you need to do anything special to prepare for your breathing tests. If you take an inhaler, your doctor might have you wait to take your medicine after the test (instead of before).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H260645252\">",
"      <span class=\"h1\">",
"       What are the different breathing tests and what do they involve?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The different breathing tests include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Spirometry &ndash; This is the breathing test most commonly done. It involves breathing in as deeply as you can, and then breathing out as hard and as fast as you can into a tube (",
"        <a class=\"graphic graphic_figure graphicRef84004 \" href=\"mobipreview.htm?0/61/981\">",
"         figure 1",
"        </a>",
"        ). The tube is attached to a machine called a &ldquo;spirometer.&rdquo; The doctor, nurse, or technician will give you specific directions about how to breathe for the test. Spirometry measures how much air you can breathe in and out of your lungs and how fast you can breathe the air out of your lungs.",
"        <br/>",
"        <br/>",
"        During this test, the doctor, nurse, or technician might give you medicine to open up your airways. This medicine comes as an inhaler that you breathe in. Then, you will repeat the spirometry test to see whether the medicine has affected your breathing.",
"       </li>",
"       <li>",
"        Lung volume measurement &ndash; This test measures how much air is in your lungs. Some lung diseases increase the amount of air in your lungs. Other diseases decrease the amount of air in your lungs. The test involves sitting in a large glass box that looks like a phone booth. While you are in this box, you will breathe in and out through a tube. The technician might ask you to pant (breathe in and out quickly) during the test.",
"       </li>",
"       <li>",
"        Diffusing capacity &ndash; This test measures how well oxygen gets from your lungs into your blood. It involves breathing in a certain gas, and then breathing out into a tube.",
"       </li>",
"       <li>",
"        Six-minute walk test &ndash; This test measures how far you can walk in 6 minutes. It also measures how much oxygen is in your blood before and after you walk for 6 minutes. While you walk, you will wear a sensor on your finger that measures how much oxygen is in your blood.",
"       </li>",
"       <li>",
"        Arterial blood gas &ndash; This test measures how much oxygen is in your blood. It involves having blood drawn from an artery in your wrist. Then the blood sample is sent to a lab for tests.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H260645267\">",
"      <span class=\"h1\">",
"       What are the downsides of breathing tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It depends on the test. For instance, breathing in and out fast and hard during spirometry can make people cough, or feel light-headed or dizzy. It can also cause a feeling of pressure in the chest, belly, or head.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H260645282\">",
"      <span class=\"h1\">",
"       What if my child needs breathing tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most children ages 6 and older can follow directions well enough to have breathing tests.",
"     </p>",
"     <p>",
"      If your child is 5 years old or younger, the doctor can change the way the tests are done. He or she will also have the tests done by someone who has a lot of experience working with children.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H260645297\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?4/11/4275?source=see_link\">",
"       Patient information: Asthma in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/58/17315?source=see_link\">",
"       Patient information: Asthma in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/43/30386?source=see_link\">",
"       Patient information: Inhalers (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/48/15107?source=see_link\">",
"       Patient information: Chronic bronchitis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?4/59/5043?source=see_link\">",
"       Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?42/0/43011?source=see_link\">",
"       Patient information: Cough in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/7/13427?source=see_link\">",
"       Patient information: Cough in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/46/6883?source=see_link\">",
"       Patient information: Shortness of breath (dyspnea) (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/13/1236?source=see_link\">",
"       Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/34/28195?source=see_link\">",
"       Patient information: Chronic cough in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?42/11/43186?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 85379 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-E2FE460E4C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43186=[""].join("\n");
var outline_f42_11_43186=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H260645207\">",
"      What are breathing tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H260645222\">",
"      Why might my doctor order breathing tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H260645237\">",
"      How do I prepare for breathing tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H260645252\">",
"      What are the different breathing tests and what do they involve?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H260645267\">",
"      What are the downsides of breathing tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H260645282\">",
"      What if my child needs breathing tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H260645297\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/85379\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/61/981\">",
"      Spirometry (breathing test)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?4/11/4275?source=related_link\">",
"      Patient information: Asthma in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/58/17315?source=related_link\">",
"      Patient information: Asthma in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/48/15107?source=related_link\">",
"      Patient information: Chronic bronchitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/34/28195?source=related_link\">",
"      Patient information: Chronic cough in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/13/1236?source=related_link\">",
"      Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?4/59/5043?source=related_link\">",
"      Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?42/0/43011?source=related_link\">",
"      Patient information: Cough in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/7/13427?source=related_link\">",
"      Patient information: Cough in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/43/30386?source=related_link\">",
"      Patient information: Inhalers (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/46/6883?source=related_link\">",
"      Patient information: Shortness of breath (dyspnea) (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_11_43187="Nail anatomy 3";
var content_f42_11_43187=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85616&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85616&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 511px\">",
"   <div class=\"ttl\">",
"    Anatomy of the nail apparatus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 491px; height: 598px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43187=[""].join("\n");
var outline_f42_11_43187=null;
var title_f42_11_43188="Roflumilast: Patient drug information";
var content_f42_11_43188=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Roflumilast: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/15/35060?source=see_link\">",
"     see \"Roflumilast: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F12918639\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Daliresp&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F11450895\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Daxas&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F11989651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F11562184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691768",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat breathing problems.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F11562107\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3069559",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to roflumilast or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703781",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701052",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are having a breathing attack.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F11562109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697307",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have mental illness, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F11562187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698017",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698393",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F11562111\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699102",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not able to get the breathing attack under control.",
"       <b>",
"        Get help right away.",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699064",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F11562186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F11562108\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F11562188\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F11562112\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16466 Version 19.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.111.122.2-6B4A64F196-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43188=[""].join("\n");
var outline_f42_11_43188=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12918639\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11450895\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11989651\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11562184\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11562107\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11562109\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11562187\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11562111\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11562186\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11562108\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11562188\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11562112\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?34/15/35060?source=related_link\">",
"      Roflumilast: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_11_43189="Fetal anal atresia with rectovaginal fistula";
var content_f42_11_43189=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F76382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F76382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound and magnetic resonance images of anal atresia with rectovaginal fistula",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 577px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Ultrasound. Coronal view of the abdomen at 22 weeks of gestation shows the fluid filled rectosigmoid colon containing intraluminal calcifications.",
"    <br>",
"     (B and C) Magnetic resonance imaging. Coronal and sagittal T2w images of the fetal abdomen confirm the presence of fluid within the distal rectosigmoid coursing posterior and inferiot to the baldder base.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Courtesy of Dorothy I Bulas, MD.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43189=[""].join("\n");
var outline_f42_11_43189=null;
var title_f42_11_43190="Pharmacology of flucytosine (5-FC)";
var content_f42_11_43190=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pharmacology of flucytosine (5-FC)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/11/43190/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/11/43190/contributors\">",
"     Richard H Drew, PharmD, MS, BCPS, FCCP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/11/43190/contributors\">",
"     John R Perfect, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/11/43190/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/11/43190/contributors\">",
"     Carol A Kauffman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/11/43190/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/11/43190/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/11/43190/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/0/32773?source=see_link\">",
"     Flucytosine",
"    </a>",
"    (5-flucytosine, 5-FC, Ancobon) is an antifungal agent originally developed in 1957 as an antimetabolite. Although it has found no role as an anti-tumor agent, it is used for the treatment of certain fungal infections.",
"   </p>",
"   <p>",
"    Due to a high incidence of primary",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    acquired resistance, use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/0/32773?source=see_link\">",
"     flucytosine",
"    </a>",
"    as monotherapy is significantly restricted. Combination therapy of 5-FC with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    is recommended for the initial management of severe cryptococcal pneumonia and meningoencephalitis infections and (less frequently) in select invasive candidal infections.",
"   </p>",
"   <p>",
"    Hematologic and hepatic toxicities may occur with 5-FC administration, but can be reduced by monitoring serum concentrations and by adjusting the dose empirically in patients with renal dysfunction.",
"   </p>",
"   <p>",
"    The pharmacology of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/0/32773?source=see_link\">",
"     flucytosine",
"    </a>",
"    will be discussed here. The clinical use of flucytosine is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/61/40919?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/54/15210?source=see_link\">",
"     \"Treatment of cryptococcal meningoencephalitis and disseminated infection in HIV seronegative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/39/40566?source=see_link\">",
"     \"Candida endocarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/40/39559?source=see_link\">",
"     \"Candida infections of the central nervous system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MECHANISMS OF ACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;5-FC exerts its antifungal effects by interfering with both DNA and protein synthesis. 5-FC is transported into susceptible fungi by cytosine permease, then deaminated to 5-",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    (5-FU) by cytosine deaminase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/1\">",
"     1",
"    </a>",
"    ]. The absence of cytosine deaminase in mammalian cells allows selective effects on fungal cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Following incorporation into DNA, 5-FU is converted to 5-fluorodeoxyuridylic acid monophosphate, which interferes with DNA synthesis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      5-FC inhibits protein synthesis by a separate mechanism; 5-FU is converted through 5-fluorouridine monophosphate and 5-fluorouridine diphosphate into 5-fluorouridine triphosphate, which is incorporated into fungal RNA, thereby disturbing the amino acid pool and preventing protein synthesis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The net result antifungal activity may be static or cidal, depending upon the organism.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/0/32773?source=see_link\">",
"     Flucytosine",
"    </a>",
"    has demonstrated a prolonged post-antifungal effect (up to four hours) and concentration-independent pharmacodynamic activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL USES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combination therapy of 5-FC with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    is recommended for the initial management of severe cryptococcal pneumonia and meningoencephalitis and, less frequently, in select invasive candidal infections.",
"   </p>",
"   <p>",
"    Due to a high incidence of primary",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    acquired resistance, use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/0/32773?source=see_link\">",
"     flucytosine",
"    </a>",
"    as monotherapy is significantly restricted. &nbsp;Monotherapy with 5-FC may be considered in selected cases of",
"    <span class=\"nowrap\">",
"     chromoblastomycosis/phaeohyphomycosis",
"    </span>",
"    and genitourinary non-albicans candidal infections that are not life-threatening and for which treatment alternatives, such as azoles, are not possible.",
"   </p>",
"   <p>",
"    The clinical uses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/0/32773?source=see_link\">",
"     flucytosine",
"    </a>",
"    are discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/23/23929?source=see_link\">",
"     \"Treatment of cryptococcal meningoencephalitis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/54/15210?source=see_link\">",
"     \"Treatment of cryptococcal meningoencephalitis and disseminated infection in HIV seronegative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/39/40566?source=see_link\">",
"     \"Candida endocarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/40/39559?source=see_link\">",
"     \"Candida infections of the central nervous system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MECHANISMS OF RESISTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resistance to 5-FC can result from primary (intrinsic) or acquired resistance. Intrinsic resistance is due to impaired cellular uptake secondary to a mutation in cytosine permease. Acquired resistance results from defects in",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/0/32773?source=see_link\">",
"     flucytosine",
"    </a>",
"    metabolism through mutations in cytosine deaminase or uracil phosphoribosyl transferase, and is thought to be a result of either failure of the organism to metabolize the agent, or loss of pyrimidine biosynthesis feedback control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In vitro data from clinical isolates do not always accurately reflect the incidence of resistance to 5-FC. As an example, C. albicans demonstrating heterozygous resistance traits are frequently seen among clinical strains. These isolates demonstrate only slight increases in MICs in vitro. However, under clinical conditions of drug exposure, selection of organisms that are more resistant may lead to treatment failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ANTIMICROBIAL ACTIVITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Clinical and Laboratory Standards Institute (CLSI, formerly the National Committee on Laboratory Standards) has established methods to standardize in vitro testing against Candida spp.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Cryptococcus neoformans",
"    </span>",
"    &nbsp;&mdash;&nbsp;The in vitro activity of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/0/32773?source=see_link\">",
"     flucytosine",
"    </a>",
"    against Cryptococcus spp varies significantly among reports. Primary resistance rates have been reported to have ranged from 1 to 25 percent of C. neoformans isolates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. Non-neoformans strains of Cryptococcus may exhibit higher MICs to 5-FC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The in vitro activity of the combination of 5-FC with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    against cryptococcal isolates is generally at least additive in 5-FC-susceptible isolates. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/4/36938?source=see_link\">",
"     \"Pharmacology of azoles\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Candida",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reports of in vitro activity of 5-FC against Candida spp have varied by geographic location and species [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. The reported incidence of resistance of Candida albicans to 5-FC ranges from 4 to 15 percent. Most strains of C. glabrata are susceptible to 5-FC. In one report, over 8800 Candida isolates obtained globally were tested for intrinsic resistance to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/0/32773?source=see_link\">",
"     flucytosine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/11\">",
"     11",
"    </a>",
"    ]. Overall, 95 percent of the isolates evaluated demonstrated in vitro susceptibility. With the exception of C. krusei (only 5 percent susceptible), resistance among a variety of Candida spp tested was uncommon. A later study that tested the in vitro activity of 5-FC against 254 clinical isolates of C. krusei collected worldwide, found a similar rate of susceptibility (8 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although infrequent, clonal outbreaks of 5-FC resistance in select Candida spp have been reported. In one such report, 45 (35 percent) of 130 C. tropicalis bloodstream isolates over a 4 year period were reported to be 5-FC resistant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/13\">",
"     13",
"    </a>",
"    ]. The resistant clone was seen more commonly in patients with malignancies, particularly hematologic malignancies.",
"   </p>",
"   <p>",
"    When 5-FC is tested in vitro in combination with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    against Candida spp, an additive effect or synergy was reported in 35 of 40 (85 percent) of isolates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Other fungi",
"    </span>",
"    &nbsp;&mdash;&nbsp;5-FC demonstrates activity in vitro against less pathogenic fungi including Rhodotorula spp and Saccharomyces cerevisiae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. In addition, most organisms responsible for chromoblastomycosis and some dematiaceous fungi (Cladophialophora spp, Phialophora spp) are susceptible to 5-FC in vitro [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The endemic mycoses (Histoplasma, Blastomyces, Coccidioides species), most Aspergillus species, zygomycetes, and most dermatophytes are considered resistant in vitro to 5-FC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PHARMACOKINETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;5-FC is available only as an oral capsule in the United States, although an IV formulation is available in Europe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/17\">",
"     17",
"    </a>",
"    ]. Approximately 80 to 90 percent of 5-FC is absorbed following oral administration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/18\">",
"     18",
"    </a>",
"    ]. Peak serum levels of 30 to 45",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    occur one to two hours after a single oral dose of 150",
"    <span class=\"nowrap\">",
"     mg/kg.",
"    </span>",
"    Oral absorption of 5-FC may be reduced in patients with advanced AIDS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    5-FC is widely distributed due in part to a low degree of protein binding (approximately 4 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/5\">",
"     5",
"    </a>",
"    ]. The volume of distribution ranges from 0.6 to 0.9",
"    <span class=\"nowrap\">",
"     L/kg",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/5\">",
"     5",
"    </a>",
"    ]. Favorable penetration into bone, vertebral discs, and peritoneal and synovial fluid has been documented. Drug concentrations achieved in the spleen, heart, liver, kidney, and lung are equal to those found in the serum. 5-FC levels in the cerebrospinal fluid are approximately 60 to 80 percent of simultaneous serum levels, whereas urine levels are generally several-fold higher than simultaneous serum levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Up to 96 percent of the total dose of 5-FC is eliminated as unchanged drug in the urine, primarily by glomerular filtration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/5\">",
"     5",
"    </a>",
"    ]. The elimination half-life of 5-FC ranges from three to eight hours (average six hours) in patients with normal renal function, but may extend for up to 60 to 250 hours in patients with end-stage renal disease. Both hemodialysis and peritoneal dialysis remove significant amounts of 5-FC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DOSING",
"    </span>",
"    &nbsp;&mdash;&nbsp;5-FC should be given orally in four divided doses (25",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    at six hour intervals) in both adult and pediatric patients. Because of the commercial availability of a 250 mg capsule, individual oral doses are usually rounded to the nearest 250 mg, especially in adults.",
"   </p>",
"   <p>",
"    Although the published dose range of 5-FC in adults with normal renal function is 100 to 150",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, we recommend that a total dose of 100",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day not be exceeded. There is rarely an indication for doses higher than 100",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, but if used, the risk of toxicity is significant.",
"   </p>",
"   <p>",
"    Excessive serum concentrations of 5-FC have been reported in children (especially neonates) even with standard dosing of 100",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/19\">",
"     19",
"    </a>",
"    ], so careful monitoring is particularly important in such patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Dose modification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dose modification is necessary in patients with renal dysfunction. Empiric dose adjustments can be based on measured or estimated creatinine clearance:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      20 to 50",
"      <span class=\"nowrap\">",
"       mL/min:",
"      </span>",
"      <span class=\"nowrap\">",
"       1/2",
"      </span>",
"      the normal dose (12.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      every 6 hours or 25",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      every 12 hours)",
"     </li>",
"     <li>",
"      &lt;20",
"      <span class=\"nowrap\">",
"       mL/min:",
"      </span>",
"      <span class=\"nowrap\">",
"       1/4",
"      </span>",
"      the normal dose (25",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      once daily)",
"     </li>",
"     <li>",
"      Hemodialysis:",
"      <span class=\"nowrap\">",
"       1/2",
"      </span>",
"      the normal dose at end of dialysis",
"     </li>",
"     <li>",
"      Continuous ambulatory peritoneal dialysis in adults: 0.5 to 1.0 g every 24 hours",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Dosing adjustment is not necessary in patients with hepatic insufficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SERUM CONCENTRATION MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monitoring of serum 5-FC concentrations is performed in order to reduce the risk of toxicity, particularly hematologic toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. It is particularly important to monitor the 5-FC concentration in patients with renal dysfunction, since the drug accumulates in this setting, which can lead to toxicity. In a retrospective study that included 53 intensive care unit patients, patients with serum concentrations &gt;100",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    were significantly more likely to develop thrombocytopenia and hepatotoxicity than those with lower serum concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Measurement of serum 5-FC concentrations is recommended after three to five days of therapy when available, and should be obtained two hours after a dose has been administered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/23\">",
"     23",
"    </a>",
"    ]. Guidelines for the treatment of cryptococcal infections recommend peak concentrations between 30 and 80",
"    <span class=\"nowrap\">",
"     mcg/mL;",
"    </span>",
"    concentrations &gt;100",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    should be avoided [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/23\">",
"     23",
"    </a>",
"    ]. Serum drug concentrations should be repeated if renal function worsens, or if leukopenia or thrombocytopenia occurs.",
"   </p>",
"   <p>",
"    All patients receiving 5-FC should undergo regular monitoring of the complete blood count (CBC). In settings in which serum 5-FC concentrations are not available, CBC monitoring two to three times per week provides an indirect method of screening for excessive dosing. An otherwise unexplained reduction in the neutrophil or platelet count may reflect 5-FC toxicity and either the drug should be stopped or the dose reduced.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     ADVERSE EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most significant toxicities of 5-FC are hematologic, hepatic, and gastrointestinal. In particular, leukopenia and thrombocytopenia can limit its use.",
"   </p>",
"   <p>",
"    Most of the hematologic toxicity associated with 5-FC is thought to result from the in vivo conversion of 5-FC to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    (5-FU). 5-FC may convert to 5-FU spontaneously or under the influence of E. coli in the gut [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/24\">",
"     24",
"    </a>",
"    ]. Although the enzyme or enzymes responsible for this conversion are thought to be induced by chronic exposure, toxicity most often occurs during the first two weeks of treatment. Renal dysfunction caused by the concomitant administration of nephrotoxic agents, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    , can lead to 5-FC accumulation and further contribute to dose-related toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 5 percent of patients develop elevations in serum aminotransferases or alkaline phosphatase, and hepatic necrosis has been reported. As a result, a strong indication must be present to justify administration of 5-FC to patients with severe liver dysfunction. These hematologic and hepatic abnormalities are seen primarily in patients whose peak serum 5-FC concentrations exceed 100",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/22\">",
"     22",
"    </a>",
"    ]. Gastrointestinal complaints such as nausea, vomiting, and diarrhea occur in up to 6 percent of patients. However, such reactions are less clearly related to serum concentrations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF TOXICITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dosage reductions in patients with preexisting renal dysfunction or in those with excessive serum concentrations may help to reduce hematologic and hepatic toxicities resulting from 5-FC administration. While further dose reductions (resulting in reductions in serum concentrations) may permit the continuation of therapy, it would generally not be advisable to reduce serum concentrations below target. In most clinical scenarios, alternate therapies exist, which facilitate the ability to discontinue therapy in patients for whom toxicity is severe.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DRUG INTERACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Concomitant",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/16/27910?source=see_link\">",
"     aluminum hydroxide",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/6/31847?source=see_link\">",
"     magnesium hydroxide",
"    </a>",
"    delays absorption of 5-FC. The effect of other drugs that raise gastric pH (such as other antacids, histamine-2 antagonists, or proton pump inhibitors) has not been reported. 5-FC is not known to affect the hepatic cytochrome P450 system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/18,26\">",
"     18,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Concomitant administration of agents with toxicities similar to 5-FC should be approached with caution. As an example, patients with AIDS who are treated with 5-FC for cryptococcal meningitis may be receiving other agents with hematologic toxicities, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/28/24008?source=see_link\">",
"     zidovudine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/30/33248?source=see_link\">",
"     ganciclovir",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    . In addition, drugs known to cause renal dysfunction (such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/56/29575?source=see_link\">",
"     foscarnet",
"    </a>",
"    ) may alter the elimination of 5-FC and predispose to toxicities related to excessive 5-FC concentrations.",
"   </p>",
"   <p>",
"    Although the product information document states that the antifungal activity of 5-FC can be competitively inhibited by",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/53/20314?source=see_link\">",
"     cytarabine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43190/abstract/22\">",
"     22",
"    </a>",
"    ], there are no published data to support this.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the in vivo conversion of 5-FC to 5-",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    , 5-FC is relatively contraindicated in pregnancy. 5-FU is suspected of being capable of producing congenital anomalies in humans, and 5-FC has been shown to be teratogenic in rats. It is classified as pregnancy category C. However, 5-FC has been reported to have been used during pregnancy in several cases without complications. It may be necessary to use 5-FC with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    in some pregnant patients with cryptococcal meningitis, but the decision to use this agent clearly must be discussed with and agreed upon by the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/0/32773?source=see_link\">",
"       Flucytosine",
"      </a>",
"      (5-FC) exerts its antifungal effects by interfering with both DNA and protein synthesis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Mechanisms of action'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      5-FC (in combination with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      deoxycholate or a lipid formulation of amphotericin B) is the induction therapy of choice for cryptococcal meningoencephalitis and severe cryptococcal pneumonia. It is used less commonly as part of a combination regimen for select invasive candidal infections. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical uses'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Due to a high incidence of primary",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      acquired resistance, use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/0/32773?source=see_link\">",
"       flucytosine",
"      </a>",
"      as monotherapy is significantly restricted. Select cases of",
"      <span class=\"nowrap\">",
"       chromoblastomycosis/phaeohyphomycosis",
"      </span>",
"      and genitourinary non-albicans candidal infections that are not life-threatening and for which treatment alternatives, such as azoles, are not possible may be considered for monotherapy. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Mechanisms of resistance'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical uses'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Resistance to 5-FC is thought to be a result of either failure of the organism to metabolize the agent, or loss of pyrimidine biosynthesis feedback control. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Mechanisms of resistance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      5-FC has activity in vitro against Cryptococcus neoformans, many Candida spp, Rhodotorula spp, Saccharomyces cerevisiae, most of the organisms responsible for chromoblastomycosis, and some dematiaceous fungi. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Antimicrobial activity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/0/32773?source=see_link\">",
"       Flucytosine",
"      </a>",
"      is available in the United States only as an oral capsule. Approximately 80 to 90 percent of 5-FC is absorbed following oral administration. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Pharmacokinetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The usual dosing of 5-FC in patients with normal renal function is 25",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      orally every six hours. Because of the commercial availability of a 250 mg capsule, individual oral doses are usually rounded to the nearest 250 mg, especially in adults. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Dosing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dose modification is necessary in patients with renal dysfunction. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Dose modification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most significant toxicities of 5-FC are hematologic, hepatic, and gastrointestinal. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Adverse effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serum 5-FC concentrations should be monitored in order to reduce the risk of toxicities, particularly hematologic toxicity. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Serum concentration monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Measurement of serum 5-FC concentrations is recommended after three to five days of therapy, when available, and should be obtained two hours after a dose has been administered. Peak serum concentrations should be between 30 and 80",
"      <span class=\"nowrap\">",
"       mcg/mL;",
"      </span>",
"      concentrations &gt;100",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"      should be avoided. In settings in which serum 5-FC concentrations are not available, complete blood count monitoring two to three times per week provides an indirect method of screening for excessive dosing. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Serum concentration monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because of the in vivo conversion of 5-FC to 5-",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/32/33280?source=see_link\">",
"       fluorouracil",
"      </a>",
"      , 5-FC is contraindicated in pregnancy. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Pregnancy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/1\">",
"      Polak A, Scholer HJ. Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy 1975; 21:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/2\">",
"      Vermes A, Guchelaar HJ, Dankert J. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 2000; 46:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/3\">",
"      Dodds ES, Drew RH, Perfect JR. Antifungal pharmacodynamics: review of the literature and clinical applications. Pharmacotherapy 2000; 20:1335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/4\">",
"      Andes D, van Ogtrop M. In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model. Antimicrob Agents Chemother 2000; 44:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/5\">",
"      Vanden Bossche H, Dromer F, Improvisi I, et al. Antifungal drug resistance in pathogenic fungi. Med Mycol 1998; 36 Suppl 1:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/6\">",
"      Chin CS, Cheong YM, Wong YH. 5-Fluorocytosine resistance in clinical isolates of Cryptococcus neoformans. Med J Malaysia 1989; 44:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/7\">",
"      Shadomy HJ, Wood-Helie S, Shadomy S, et al. Biochemical serogrouping of clinical isolates of Cryptococcus neoformans. Diagn Microbiol Infect Dis 1987; 6:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/8\">",
"      Franzot SP, Hamdan JS. In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs. Antimicrob Agents Chemother 1996; 40:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/9\">",
"      Bava AJ, Negroni R. [In vitro susceptibility of Cryptococcus strains to 5 antifungal drugs]. Rev Inst Med Trop Sao Paulo 1989; 31:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/10\">",
"      Pujol C, Pfaller MA, Soll DR. Flucytosine resistance is restricted to a single genetic clade of Candida albicans. Antimicrob Agents Chemother 2004; 48:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/11\">",
"      Pfaller MA, Messer SA, Boyken L, et al. In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrob Agents Chemother 2002; 46:3518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/12\">",
"      Pfaller MA, Diekema DJ, Gibbs DL, et al. Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. J Clin Microbiol 2008; 46:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/13\">",
"      Desnos-Ollivier M, Bretagne S, Bern&egrave;de C, et al. Clonal population of flucytosine-resistant Candida tropicalis from blood cultures, Paris, France. Emerg Infect Dis 2008; 14:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/14\">",
"      Montgomerie JZ, Edwards JE Jr, Guze LB. Synergism of amphotericin B and 5-fluorocytosine for candida species. J Infect Dis 1975; 132:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/15\">",
"      Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review. J Antimicrob Chemother 2005; 55:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/16\">",
"      Diekema DJ, Petroelje B, Messer SA, et al. Activities of available and investigational antifungal agents against rhodotorula species. J Clin Microbiol 2005; 43:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/17\">",
"      Brouwer AE, van Kan HJ, Johnson E, et al. Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitis. Antimicrob Agents Chemother 2007; 51:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/18\">",
"      Daneshmend TK, Warnock DW. Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokinet 1983; 8:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/19\">",
"      Soltani M, Tobin CM, Bowker KE, et al. Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory. Int J Antimicrob Agents 2006; 28:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/20\">",
"      Goodwin ML, Drew RH. Antifungal serum concentration monitoring: an update. J Antimicrob Chemother 2008; 61:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/21\">",
"      Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob Agents Chemother 2009; 53:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/22\">",
"      Vermes A, van Der Sijs H, Guchelaar HJ. Flucytosine: correlation between toxicity and pharmacokinetic parameters. Chemotherapy 2000; 46:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/23\">",
"      Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis 2010; 50:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/24\">",
"      Vermes A, Guchelaar HJ, van Kuilenburg AB, Dankert J. 5-fluorocytosine-related bone-marrow depression and conversion to fluorouracil: a pilot study. Fundam Clin Pharmacol 2002; 16:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/25\">",
"      Vermes A, Guchelaar HJ, Dankert J. Prediction of flucytosine-induced thrombocytopenia using creatinine clearance. Chemotherapy 2000; 46:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43190/abstract/26\">",
"      South Africa. Supreme Court, Cape Provincial Division. Castell v. De Greef. S Afr Law Rep 1994; 1994:408.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 472 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-22DD962998-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43190=[""].join("\n");
var outline_f42_11_43190=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MECHANISMS OF ACTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL USES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MECHANISMS OF RESISTANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ANTIMICROBIAL ACTIVITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Cryptococcus neoformans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Candida",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Other fungi",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PHARMACOKINETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DOSING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Dose modification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SERUM CONCENTRATION MONITORING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ADVERSE EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      MANAGEMENT OF TOXICITIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DRUG INTERACTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/39/40566?source=related_link\">",
"      Candida endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/40/39559?source=related_link\">",
"      Candida infections of the central nervous system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/61/40919?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/4/36938?source=related_link\">",
"      Pharmacology of azoles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/54/15210?source=related_link\">",
"      Treatment of cryptococcal meningoencephalitis and disseminated infection in HIV seronegative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/23/23929?source=related_link\">",
"      Treatment of cryptococcal meningoencephalitis in HIV-infected patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_11_43191="Atrial flutter Entrainment";
var content_f42_11_43191=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1070px;\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Entrainment in type I atrial flutter with right atrial pacing with the rate of recording by the ECG machine being slowed by one-half",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 173px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The spontaneous rhythm, in which the flutter waves are not clearly apparent, is shown in the left side of panel A. The right atrium is then paced at just under 400 beats/min; entrainment is achieved at the asterisk when there is a sudden change in atrial morphology as the flutter rate matched the pacing rate. Cessation of pacing led to conversion to sinus rhythm (panel B).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal rhythm strip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 165px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton F Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43191=[""].join("\n");
var outline_f42_11_43191=null;
var title_f42_11_43192="Clinical presentation and diagnosis of measles";
var content_f42_11_43192=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical presentation and diagnosis of measles",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/11/43192/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/11/43192/contributors\">",
"     Jorge L Barinaga, MD, MS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/11/43192/contributors\">",
"     Paul R Skolnik, MD, FACP, FIDSA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/11/43192/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/11/43192/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/11/43192/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/11/43192/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/11/43192/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/11/43192/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 17, 2010.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measles virus (rubeola) is a member of the family Paramyxoviridae, genus Morbillivirus. Measles virus infection can cause a variety of clinical syndromes, including [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Classic measles infection in immunocompetent patients",
"     </li>",
"     <li>",
"      Modified measles in patients with preexisting, but incompletely protective, anti-measles antibody",
"     </li>",
"     <li>",
"      Atypical measles in patients immunized with the killed virus vaccine",
"     </li>",
"     <li>",
"      Neurologic syndromes following measles infection, including acute disseminated encephalomyelitis (ADEM) and subacute sclerosing panencephalitis (SSPE)",
"     </li>",
"     <li>",
"      Severe measles",
"     </li>",
"     <li>",
"      Complications of measles including secondary infection, giant cell pneumonia, and measles inclusion body encephalitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite high community vaccination coverage, measles outbreaks can occur among undervaccinated children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. The clinical manifestations and diagnosis of classic measles, variant presentations, and unusual neurologic complications will be reviewed here. The epidemiology, transmission, treatment, and prevention of measles are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/16/42246?source=see_link\">",
"     \"Epidemiology and transmission of measles\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22793?source=see_link\">",
"     \"Prevention and treatment of measles\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Stages of infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classic measles infection can be subdivided into the following clinical stages: incubation, prodrome, exanthem, and recovery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Incubation period &mdash; The incubation period begins after measles virus entry via the respiratory mucosa or conjunctivae. The virus replicates locally, spreads to regional lymphatic tissues, and is then thought to disseminate to other reticuloendothelial sites via the bloodstream. The incubation period of measles is usually 10 days with a range generally of 8 to 10 days [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/5\">",
"       5",
"      </a>",
"      ]. Infected individuals are characteristically asymptomatic during the incubation period, although some have been reported to experience transient respiratory symptoms, fever, or morbilliform rash [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6,7\">",
"       6,7",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The dissemination of measles virus due to viremia, with associated infection of endothelial, epithelial, monocyte, and macrophage cells, may explain the variety of clinical manifestations and complications that can occur with measles infection. A second viremia occurs several days after the first, coinciding with the appearance of symptoms signaling the beginning of the prodromal phase.",
"     </li>",
"     <li>",
"      Prodrome &mdash; The prodrome phase is defined by the appearance of symptoms which typically include fever, malaise, and anorexia, followed by conjunctivitis, coryza, and cough. The severity of conjunctivitis is variable and may also be accompanied by lacrimation or photophobia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6\">",
"       6",
"      </a>",
"      ]. The respiratory symptoms are due to mucosal inflammation from viral infection of epithelial cells. Fever is typically present; the pattern may be variable. Various fever patterns have been described; fever as high as 40&ordm;C can occur. The prodrome usually lasts for two to three days but may persist for as long as eight days [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/5\">",
"       5",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Patients may develop an enanthem known as Koplik's spots; these are 1 to 3 mm whitish, grayish, or bluish elevations with an erythematous base, typically seen on the buccal mucosa opposite the molar teeth, though they can spread to cover the buccal and labial mucosa (",
"      <a class=\"graphic graphic_picture graphicRef57571 \" href=\"mobipreview.htm?40/6/41070\">",
"       picture 1",
"      </a>",
"      ) as well as the hard and soft palate [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8\">",
"       8",
"      </a>",
"      ]. They have been described as \"grains of salt on a red background\" [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/7\">",
"       7",
"      </a>",
"      ]. Koplik's spots subsequently may coalesce and generally last 12 to 72 hours [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/4\">",
"       4",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      It is important to search carefully for Koplik's spots in patients with suspected measles, since they are considered pathognomonic for measles infection and occur approximately 48 hours before the characteristic exanthem. However, this enanthem does not appear in all patients with measles.",
"      <br/>",
"      <br/>",
"      Uncommonly, patients with severe measles develop generalized lymphadenopathy and splenomegaly [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Exanthem &mdash; The exanthem of measles is a maculopapular, blanching rash beginning on the face and spreading cephalocaudally and centrifugally to involve the neck, upper trunk, lower trunk, and extremities (",
"      <a class=\"graphic graphic_picture graphicRef57093 graphicRef57803 \" href=\"mobipreview.htm?40/14/41185\">",
"       picture 2A-B",
"      </a>",
"      ). The lesions may become confluent, especially in areas such as the face, where the rash develops first (",
"      <a class=\"graphic graphic_picture graphicRef57803 \" href=\"mobipreview.htm?6/12/6350\">",
"       picture 2B",
"      </a>",
"      ). The rash may also have some petechiae; in severe cases it may appear hemorrhagic [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/9-11\">",
"       9-11",
"      </a>",
"      ]. In general, the extent and degree of confluence of the rash correlates with the severity of the illness in children. The palms and soles are rarely involved. The cranial to caudal progression of the rash is characteristic of measles but is not pathognomonic [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6\">",
"       6",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Other characteristic findings during the exanthematous phase include lymphadenopathy, high fever (peaking two to three days after appearance of rash), pronounced respiratory signs including pharyngitis, and nonpurulent conjunctivitis. Koplik's spots often begin to slough when the exanthem appears.",
"      <br/>",
"      <br/>",
"      Clinical improvement typically ensues within 48 hours of the appearance of the rash. After three to four days the rash darkens to a brownish color and begins to fade, followed by fine desquamation. The rash usually lasts six to seven days.",
"     </li>",
"     <li>",
"      Recovery and immunity &mdash; Cough may persist for one to two weeks after measles infection. The occurrence of fever beyond the third to fourth day of rash suggests a measles-associated complication (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Complications'",
"      </a>",
"      below).",
"      <br/>",
"      <br/>",
"      Immunity after measles infection is thought to be lifelong, although there are rare reports of measles reinfection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]. A measles surveillance program conducted in mid 1960s, for example, identified measles in a 16-year old female with a prior history of measles at age 8. A rise in anti-measles IgG but not IgM was noted, suggesting an anamnestic response [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Modified measles'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      Measles infection can cause transient immunosuppression due to suppression of T-cell responses [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8\">",
"       8",
"      </a>",
"      ]. Anergy may be present before the appearance of the exanthem and for several weeks after measles infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8,14\">",
"       8,14",
"      </a>",
"      ]. This is exemplified by reports of tuberculosis reactivation in the setting of recent measles infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8,15\">",
"       8,15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Clinical variants",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Modified measles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Modified measles is an attenuated measles infection that occurs in patients with preexisting but incompletely protective anti-measles antibody. It is similar to classic measles except the clinical manifestations are generally milder and the incubation period is longer (17 to 21 days) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/5\">",
"     5",
"    </a>",
"    ]. Individuals with partial immunity to measles can develop modified measles; partial immunity may occur in one of the following ways:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Transplacental transfer of partially protective anti-measles antibody from mother to infant; this antibody is generally cleared by age nine months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Receipt of intravenous immunoglobulin",
"     </li>",
"     <li>",
"      Measles vaccination with incomplete antibody response",
"     </li>",
"     <li>",
"      Prior history of measles [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/13\">",
"       13",
"      </a>",
"      ]&nbsp;(see",
"      <a class=\"local\" href=\"#H3\">",
"       'Stages of infection'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Atypical measles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atypical measles occurred in patients immunized with the killed virus vaccine subsequently exposed to wild-type measles virus. Since the killed virus vaccine was used in the United States between 1963 and 1967, atypical measles is now rare. The majority of cases have occurred in recipients of the killed virus vaccine, but there are also reports in recipients of the attenuated live virus vaccine.",
"   </p>",
"   <p>",
"    Patients with atypical measles develop high fever and headache 7 to 14 days after exposure to measles. A dry cough and pleuritic chest pain are often present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6\">",
"     6",
"    </a>",
"    ]. Chest x-ray typically demonstrates bilateral pulmonary nodular and hilar lymphadenopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8\">",
"     8",
"    </a>",
"    ]. A maculopapular rash develops two to three days later, beginning on the extremities and spreading to the trunk. The rash may involve the palms and soles and tends to spare the upper chest, neck, and head [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6\">",
"     6",
"    </a>",
"    ]. The rash may be vesicular, petechial, purpuric, or urticarial. The distribution and varied appearance of the rash can make diagnosis difficult.",
"   </p>",
"   <p>",
"    Atypical measles often causes severe illness; many patients develop respiratory distress. Some patients develop peripheral edema, hepatosplenomegaly,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    neurologic symptoms such as paresthesias or hyperesthesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Laboratory findings can include elevated serum aminotransferases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Atypical measles is associated with a characteristic antibody pattern: before or at the onset of the exanthem, the titer is usually &lt;1:5, but by day 10 of illness the titer is typically &ge;1:1280. The height and rapidity of antibody titer rise is much higher than in primary natural measles infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The differential diagnosis of atypical measles is broad and includes infection with varicella-zoster virus, Mycoplasma pneumoniae, Rocky Mountain spotted fever, scarlet fever, meningococcemia, Henoch-Sch&ouml;nlein purpura (IgA vasculitis), drug eruption, or toxic shock syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6,8,15\">",
"     6,8,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with atypical measles do not appear to transmit measles to others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of measles depends on the clinical stage.",
"   </p>",
"   <p>",
"    During the prodromal period measles can resemble the common cold, except that fever is typically present and more pronounced with measles infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6\">",
"     6",
"    </a>",
"    ]. The prodrome can be confused with common respiratory viruses of childhood, such as rhinoviruses, parainfluenza, influenza, adenovirus, and respiratory syncytial virus infections, and, in returning travelers, with the prodrome of Dengue fever. Koplik's spots can be mistaken for Fordyce spots (tiny yellow-white granules sometimes found on the buccal or lip mucosa due to benign ectopic sebaceous glands) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/16\">",
"     16",
"    </a>",
"    ]. Unlike Koplik's spots, Fordyce spots do not occur on an erythematous mucosal background [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once an exanthem has appeared, alternative diagnoses to consider include Mycoplasma pneumoniae, HHV-6 infection, rubella, Rocky Mountain spotted fever, infectious mononucleosis, scarlet fever, Kawasaki disease, toxic shock syndrome, dengue, and drug eruption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6,8,17\">",
"     6,8,17",
"    </a>",
"    ]. Measles can usually be distinguished clinically from rubella, erythema infectiosum (parvovirus B19 infection), roseola, and enteroviral infection by the characteristic progression of the measles rash, its subsequent brownish coloration, its blanching on pressure, and clinical history and other physical findings (especially coryza and conjunctivitis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leukopenia, T-cell cytopenia, and thrombocytopenia may be observed during measles infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6\">",
"     6",
"    </a>",
"    ]. Chest radiography may demonstrate interstitial pneumonitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Biopsy samples of lymphoid tissues before the appearance of the exanthem may demonstrate reticuloendothelial giant cells. Histologic analysis of enanthem or exanthem and cytologic examination of nasal secretions may also demonstrate epithelial giant cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of measles associated complications is increased in developing countries, where the case fatality rate is 4 to 10 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/18\">",
"     18",
"    </a>",
"    ]. Most fatalities are due to respiratory tract complications or encephalitis. Groups at increased risk for complications of measles include immunocompromised hosts, pregnant women, and individuals with vitamin A deficiency or poor nutritional status, and individuals at the extremes of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6,15,19-21\">",
"     6,15,19-21",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Groups at risk for complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Since measles is a disseminated infection, involvement of multiple organ systems can occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Pulmonary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory tract infections occur most frequently among patients &lt;5 years and &gt;20 years. Pulmonary involvement of measles infection may consist of bronchopneumonia, laryngotracheobronchitis (croup) or bronchiolitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/7,22\">",
"     7,22",
"    </a>",
"    ]. Otitis media occurs in 5 to 10 percent of cases. Measles has also been associated with development of bronchiectasis, which can predispose to recurrent respiratory infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/22\">",
"     22",
"    </a>",
"    ]. Bacterial superinfection may occur in up to 5 percent of children.",
"   </p>",
"   <p>",
"    In one retrospective study of measles fatalities in South Africa, 85 percent of deaths were attributed to viral or bacterial infections of the lung [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/22\">",
"     22",
"    </a>",
"    ]. In a series of 182 cases of measles-associated pneumonia, 89 percent occurred in association with typical measles infection; bacterial pathogens included Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, and Staphylococcus aureus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6,7,23\">",
"     6,7,23",
"    </a>",
"    ]. Coinfection with other viruses was also documented, especially parainfluenza (25 percent of patients) and adenovirus (19 percent of patients), but also with cytomegalovirus, enterovirus, influenza, and respiratory syncytial virus.",
"   </p>",
"   <p>",
"    Antibiotic prophylaxis during a measles epidemic may prevent secondary complications; further study is needed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Neurologic",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Encephalitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Encephalitis occurs in up to 1 per 1000 measles cases, usually appearing within a few days of the rash. It is associated with a CSF pleocytosis (predominantly lymphocytes), increased protein levels, and normal glucose. Most children recover from encephalitis; approximately 25 percent have neurodevelopmental sequelae, and about 15 percent may have a rapidly progressive and fatal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Acute disseminated encephalomyelitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute disseminated encephalomyelitis (ADEM) is a demyelinating disease that presents during the recovery phase of measles infection, typically within two weeks of the exanthem [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8,26\">",
"     8,26",
"    </a>",
"    ]. ADEM is also known as postinfectious or postvaccination encephalomyelitis. In contrast, subacute sclerosing panencephalitis (SSPE) presents years after initial infection. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Subacute sclerosing panencephalitis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    ADEM is thought to be caused by a postinfectious autoimmune response, rather than active measles infection of the central nervous system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8,26\">",
"     8,26",
"    </a>",
"    ]. Consistent with this hypothesis is the observation that measles virus has only rarely been isolated from the brains of patients with ADEM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/52/25416?source=see_link\">",
"     \"Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The major manifestations of ADEM include fever, headache, neck stiffness, seizures, and mental status changes such as confusion, somnolence, or coma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/15,27\">",
"     15,27",
"    </a>",
"    ]. Other findings may include ataxia, myoclonus, choreoathetosis, and signs of myelitis, such as paraplegia, quadriplegia, sensory loss, loss of bladder and bowel control, and, in patients with myelitis, back pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/27\">",
"     27",
"    </a>",
"    ]. Analysis of cerebrospinal fluid generally demonstrates a lymphocytic pleocytosis and elevated protein concentration. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/3/38968?source=see_link&amp;anchor=H3#H3\">",
"     \"Viral encephalitis in adults\", section on 'Viral versus postinfectious encephalitis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ADEM is associated with a 10 to 20 percent mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/26\">",
"     26",
"    </a>",
"    ]. Survivors frequently have residual neurologic abnormalities including behavior disorders, mental retardation, and epilepsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Subacute sclerosing panencephalitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subacute sclerosing panencephalitis (SSPE) is a fatal, progressive degenerative disease of the central nervous system that occurs 7 to 10 years after natural measles infection. Its pathogenesis is not well understood but may involve persistent infection with a genetic variant of measles virus within the central nervous system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8,28\">",
"     8,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During 1960-1974 the estimated incidence of SSPE was 8.5 cases per one million cases of measles. Between 1970 and 1980, the number of cases of SSPE fell to 0.06 cases per million population; the decline paralleled the decline of measles cases, with a lag time of several years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/29\">",
"     29",
"    </a>",
"    ]. However, data derived from the resurgence of measles infection in the United States between 1989 to 1991 suggest that the risk of SSPE may be 10-fold higher than originally estimated, based on followup study of cases of biopsy-proven SSPE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, patients with SSPE are &le;20 years and become ill 7 to 10 years after natural measles infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/30\">",
"     30",
"    </a>",
"    ]. Measles infection at an early age is a risk factor for SSPE; about half of patients with SSPE had measles before the age of 2 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/31\">",
"     31",
"    </a>",
"    ]. The risk of SSPE after measles immunization is thought to be lower than after natural measles infection; according to the CDC, the risk of SSPE following vaccination is &le; one-twelfth the risk of SSPE following infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6,29\">",
"     6,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    SSPE has been divided into the following stages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/28,31\">",
"     28,31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stage I &mdash; Stage I consists of insidious development of neurologic symptoms such as personality changes, lethargy, difficulty in school, and strange behavior. Stage I may last from weeks to years.",
"     </li>",
"     <li>",
"      Stage II &mdash; Stage II is characterized by myoclonus, worsening dementia and long tract motor or sensory disease. The patient eventually develops a highly characteristic form of myoclonus in which massive myoclonic jerks occur approximately every 5 to 10 seconds. Stage II usually lasts 3 to 12 months.",
"     </li>",
"     <li>",
"      Stages III and IV &mdash; Stages III and IV are characterized by further neurologic deterioration with eventual flaccidity or decorticate rigidity and symptoms and signs of autonomic dysfunction. Myoclonus is absent. Stage IV is a vegetative state. Death usually occurs during Stage IV but is possible in any of the stages. [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The rate of progression can be variable. Stabilization at one stage for a period of time can occur, though in general patients tend to progress from one stage to the next. Some patients have a remitting and relapsing course. Seizures can occur in any of the stages.",
"   </p>",
"   <p>",
"    Electroencephalogram (EEG) during stage II may demonstrate bursts of high-voltage complexes (300 to 1500 microvolts) of two- to three-per-second delta waves (slow waves) and sharp waves. These complexes last 0.5 to 3 seconds and occur every 3 to 20 seconds [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. Each complex is followed by a relatively flat pattern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/34\">",
"     34",
"    </a>",
"    ]. These EEG findings are characteristic of SSPE and may be pathognomonic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/28,34\">",
"     28,34",
"    </a>",
"    ]. The EEG may be abnormal in the other stages of SSPE as well [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Computed tomography of the head may show atrophy and scarring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/28\">",
"     28",
"    </a>",
"    ]. The serum anti-measles antibody concentration is elevated, and cerebrospinal fluid analysis shows elevated protein concentration and detectable anti-measles antibody [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6,8\">",
"     6,8",
"    </a>",
"    ]. Brain MR images may be normal, but in one report (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) and magnetic resonance spectroscopy (MRS) revealed substantial functional abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/36\">",
"     36",
"    </a>",
"    ]. Thus, these could be useful techniques for the early detection of SSPE and for assessing the specific brain areas affected in the early stages of SSPE when MRI findings are likely to be normal.",
"   </p>",
"   <p>",
"    The relentless and fatal course of this complication underscores the importance of measles vaccination, not only for prevention of measles but also for prevention of the severe neurologic sequelae that can ensue. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22793?source=see_link\">",
"     \"Prevention and treatment of measles\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Eye manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measles-induced keratitis (a common cause of blindness) and corneal ulceration have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6,8,37\">",
"     6,8,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other neurologic complications associated with measles include acute measles-induced encephalopathy, described in the setting of human immunodeficiency virus (HIV) infection; this manifestation is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Gastrointestinal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal complications include gingivostomatitis, diarrhea, gastroenteritis, hepatitis, mesenteric lymphadenitis and appendicitis. In developing countries, measles-induced stomatitis and diarrhea can lead to worsening of nutritional status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6,8\">",
"     6,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Cardiac",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac complications of measles include myocarditis and pericarditis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Immunosuppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measles infection can lead to systemic immune suppression and severe secondary infections, especially in the developing world [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/22,39,40\">",
"     22,39,40",
"    </a>",
"    ]. These effects are caused by direct infection of T cells by measles virus and by infection of dendritic cells, impairing their important antigen",
"    <span class=\"nowrap\">",
"     presenting/accessory",
"    </span>",
"    function in T cell activation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     GROUPS AT RISK FOR COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Groups at increased risk for complications of measles include immunocompromised hosts, pregnant women, and individuals with vitamin A deficiency or poor nutritional status, and individuals at the extremes of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6,15,19-21\">",
"     6,15,19-21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Immunocompromised patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with defects in cell-mediated immunity (AIDS, lymphoma or other malignancies) are at risk for severe, progressive measles virus infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children with HIV infection may present with measles at an earlier age than HIV-seronegative patients (10 versus 15 months) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. In addition, measles infection may have a transient suppressive effect on HIV replication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. In a study of 33 HIV-infected children hospitalized with measles, median plasma HIV RNA levels rose from 5339 at admission to 60,121",
"    <span class=\"nowrap\">",
"     copies/mL",
"    </span>",
"    at discharge; high levels of viremia persisted at one month follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The degree of infant protection against measles via placental transfer of maternal measles antibodies depends on maternal antibody titer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/45-47\">",
"     45-47",
"    </a>",
"    ]. The risk of acquiring measles before nine months of age is higher among infants born to HIV-seropositive women than those born to HIV-seronegative women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/45\">",
"     45",
"    </a>",
"    ]. In a study of 747 paired maternal-cord serum samples (91 from HIV-infected and 656 from HIV-uninfected mothers), infants born to HIV-infected mothers were more likely to be seronegative for measles; seropositive infants had 35 percent lower levels of measles antibodies compared with infants born to HIV-uninfected mothers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical presentation of measles in immunocompromised hosts may be atypical [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/19\">",
"     19",
"    </a>",
"    ]. Exanthem may be absent, evanescent, or severe and desquamative; purpura has also been described.",
"   </p>",
"   <p>",
"    Some unique measles-associated manifestations have been described in immunocompromised patients; these include giant cell pneumonia and measles inclusion body encephalitis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Giant cell pneumonia is characterized by multinucleated giant cells in lung tissue. It can develop in immunocompromised patients after classic measles or after a vague prodromal illness that may not include an exanthem [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6\">",
"       6",
"      </a>",
"      ]. In patients without a rash, lung biopsy may be required to make the diagnosis (",
"      <a class=\"graphic graphic_picture graphicRef54083 \" href=\"mobipreview.htm?40/41/41618\">",
"       picture 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Measles inclusion body encephalitis (MIBE) is characterized by histopathologic evidence of inclusions in neurons and glial cells. Patients present one to six months after exposure to measles with seizures, mental status changes, and myoclonus. MIBE may sometimes present in conjunction with giant cell pneumonia. The pathogenesis of this disorder is uncertain [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic analysis to diagnose measles in immunocompromised patients may not be useful because of deficient antibody synthesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/15\">",
"     15",
"    </a>",
"    ]. In these cases, alternative diagnostic approaches should be taken, as described below. Biopsy of involved tissues may be necessary for a definitive diagnosis. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Pregnant women",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measles in pregnancy was rare in the prevaccine era, probably because of immunity following natural measles infection when the mothers themselves were children.",
"   </p>",
"   <p>",
"    Measles during pregnancy may increase the risk for serious maternal and fetal complications. In one study of 13 peripartum women, measles infection was complicated by pneumonitis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hepatitis in nine women; four of the patients with pneumonitis had an adverse fetal outcome, and there was one maternal death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/48\">",
"     48",
"    </a>",
"    ]. The incidence of premature births was increased in one study of women who had measles while pregnant compared with matched controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/49\">",
"     49",
"    </a>",
"    ]. Measles may also lead to spontaneous abortion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A review of the teratogenicity of measles virus concluded that \"[t]he teratogenic potential of gestational measles for the fetus has been neither proved nor refuted,\" and \"if there is any increased risk of malformations from gestational measles, this risk appears to be small\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/50\">",
"     50",
"    </a>",
"    ]. Investigation of a measles epidemic in 1951 found no clear evidence of teratogenicity, increased pathogenicity in the mother, or altered sequelae during pregnancy or birth; however, case finding and follow-up were not complete [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Maternal measles virus infection at the time of delivery does not necessarily lead to measles in the neonate. Congenital measles (defined by the appearance of the measles rash within 10 days of birth) and postnatally-acquired measles (appearance of the rash 14 to 30 days of birth) have been associated with a spectrum of illnesses ranging from mild to severe disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In countries with very low measles prevalence, diagnosis should consist of evaluation of paired acute and convalescent sera for anti-measles IgM and IgG; at least fourfold increase in anti-measles antibody titer is indicative of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/52,53\">",
"     52,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Anti-measles IgM is generally detectable three days after the appearance of the exanthem; it may be undetectable on the day the exanthem appears [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/52\">",
"     52",
"    </a>",
"    ]. It is usually undetectable approximately 30 days after the exanthem. Anti-measles IgG is generally undetectable up to seven days after rash onset [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/52\">",
"     52",
"    </a>",
"    ], but subsequently peaks about 14 days after the exanthem appears.",
"   </p>",
"   <p>",
"    In countries with high measles prevalence, the World Health Organization (WHO) uses serum IgM as the standard test to confirm the diagnosis of measles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/52,54\">",
"     52,54",
"    </a>",
"    ]. However, the anti-measles IgM assay should be interpreted with caution as false positive and false negative results have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8,52\">",
"     8,52",
"    </a>",
"    ]. In one study, at least some false positive results were found to result from human parvovirus B19 IgM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Histologic evaluation of conjunctival, nasopharyngeal, or buccal epithelial cells may demonstrate giant cells with inclusions (",
"    <a class=\"graphic graphic_picture graphicRef54083 \" href=\"mobipreview.htm?40/41/41618\">",
"     picture 3",
"    </a>",
"    ); these cells may also be present in urine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of measles can also be made by culturing the virus from peripheral blood mononuclear cells, respiratory secretions, conjunctival swabs, or urine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/8\">",
"     8",
"    </a>",
"    ]. Measles virus has been isolated from nasopharyngeal secretions during the prodromal phase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6\">",
"     6",
"    </a>",
"    ]. However, culture of the virus is difficult, requires special facilities, and is not performed frequently.",
"   </p>",
"   <p>",
"    In the United States, a case of suspected or confirmed measles should be reported to the local health authorities; even one case is considered an outbreak [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    Basics topics (see",
"    <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/56/2947?source=see_link\">",
"     \"Patient information: Measles (The Basics)\"",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Classic measles infection in immunocompetent patients consists of the following clinical stages: incubation, prodrome, exanthem, and recovery. The prodrome phase is characterized by fever, malaise, and anorexia, followed by conjunctivitis, coryza, and cough. Patients may develop an enanthem known as Koplik's spots; they are considered pathognomonic for measles infection and occur approximately 48 hours before the characteristic exanthem (",
"      <a class=\"graphic graphic_picture graphicRef57093 graphicRef57803 \" href=\"mobipreview.htm?40/14/41185\">",
"       picture 2A-B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Stages of infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical variants include modified measles in patients with preexisting, but incompletely protective anti-measles antibody, and atypical measles in patients immunized with the killed virus vaccine subsequently exposed to wild-type measles virus. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical variants'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neurologic syndromes following measles infection include acute disseminated encephalomyelitis (ADEM) and subacute sclerosing panencephalitis (SSPE). ADEM is a demyelinating disease that presents during the recovery phase of measles infection and is thought to be caused by a postinfectious autoimmune response. SSPE is a progressive degenerative disease of the central nervous system that occurs 7 to 10 years after natural measles infection; its pathogenesis may involve persistent infection with a genetic variant of measles virus within the central nervous system. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Acute disseminated encephalomyelitis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Subacute sclerosing panencephalitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other complications include secondary bacterial infection, giant cell pneumonia, and measles inclusion body encephalitis. Groups at increased risk for complications of measles include immunocompromised hosts, pregnant women, individuals with vitamin A deficiency or poor nutritional status, and individuals at the extremes of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/11/43192/abstract/6,15,19-21\">",
"       6,15,19-21",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Complications'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Groups at risk for complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In countries with very low measles prevalence, diagnosis should consist of evaluation of paired acute and convalescent sera for anti-measles IgM and IgG; at least fourfold increase in anti-measles antibody titer is indicative of infection. In countries with high measles prevalence, the World Health Organization (WHO) uses serum IgM as the standard test to confirm the diagnosis of measles. However, the anti-measles IgM assay should be interpreted with caution as false positive and false negative results have been reported. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/1\">",
"      Moss WJ, Griffin DE. Measles. Lancet 2012; 379:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/2\">",
"      Sugerman DE, Barskey AE, Delea MG, et al. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Pediatrics 2010; 125:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/3\">",
"      Centers for Disease Control and Prevention (CDC). Update: measles--United States, January-July 2008. MMWR Morb Mortal Wkly Rep 2008; 57:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/4\">",
"      Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis 2004; 189 Suppl 1:S4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/5\">",
"      BABBOTT FL Jr, GORDON JE. Modern measles. Am J Med Sci 1954; 228:334.",
"     </a>",
"    </li>",
"    <li>",
"     Cherry JD. Measles virus. In: Textbook of Pediatric Infectious Diseases, 6th ed, Feigin RD, Cherry JD, Demmler-Harrison GJ, et al (Eds), Saunders, Philadelphia 2009. p.2427.",
"    </li>",
"    <li>",
"     Bernstein DI, Schiff GM. Measles. In: Infectious Diseases, Gorbach SL, Bartlett JG, Blacklow NR (Eds), WB Saunders, Philadelphia 1998. p.1296.",
"    </li>",
"    <li>",
"     Griffin DE, Bellini WJ. Measles virus. In: Fields' Virology, Fields BN, Knipe DM, Howley PM (Eds), Lippincott-Raven, Philadelphia 1996. p.1267.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/9\">",
"      HUDSON JB, WEINSTEIN L, CHANG TW. Thrombocytopenic purpura in measles. J Pediatr 1956; 48:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/10\">",
"      Abramson O, Dagan R, Tal A, Sofer S. Severe complications of measles requiring intensive care in infants and young children. Arch Pediatr Adolesc Med 1995; 149:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/11\">",
"      Suringa DW, Bank LJ, Ackerman AB. Role of measles virus in skin lesions and Koplik's spots. N Engl J Med 1970; 283:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/12\">",
"      Schaffner W, Schluederberg AE, Byrne EB. Clinical epidemiology of sporadic measles in a highly immunized population. N Engl J Med 1968; 279:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/13\">",
"      Cherry JD, Feigin RD, Lobes LA Jr, et al. Urban measles in the vaccine era: a clinical, epidemiologic, and serologic study. J Pediatr 1972; 81:217.",
"     </a>",
"    </li>",
"    <li>",
"     Sissons JG, Borysiewicz LK. Viruses. In: Clinical Aspects of Immunology, Lachmann PJ, Peters K, Rosen FS, et al. (Eds), Blackwell Scientific, Boston 1993. p.1497.",
"    </li>",
"    <li>",
"     Gershon AA. Measles virus (rubeola). In: Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, New York City 1995. p.1519.",
"    </li>",
"    <li>",
"     Darmstadt GL, Lane A. Disorders of the mucous membranes. In: Nelson Textbook of Pediatrics, 15th ed, WB Saunders, Philadelphia 1996. p.1888.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/17\">",
"      Laboratory diagnosis of measles infection and monitoring of measles immunization: memorandum from a WHO meeting. Bull World Health Organ 1994; 72:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/18\">",
"      Nandy R, Handzel T, Zaneidou M, et al. Case-fatality rate during a measles outbreak in eastern Niger in 2003. Clin Infect Dis 2006; 42:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/19\">",
"      Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA 1992; 267:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/20\">",
"      CHRISTENSEN PE, SCHMIDT H, BANG HO, et al. An epidemic of measles in southern Greenland, 1951; measles in virgin soil. III. Measles and tuberculosis. Acta Med Scand 1953; 144:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/21\">",
"      Arya LS, Taana I, Tahiri C, et al. Spectrum of complications of measles in Afghanistan: a study of 784 cases. J Trop Med Hyg 1987; 90:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/22\">",
"      Beckford AP, Kaschula RO, Stephen C. Factors associated with fatal cases of measles. A retrospective autopsy study. S Afr Med J 1985; 68:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/23\">",
"      Quiambao BP, Gatchalian SR, Halonen P, et al. Coinfection is common in measles-associated pneumonia. Pediatr Infect Dis J 1998; 17:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/24\">",
"      Garly ML, Bal&eacute; C, Martins CL, et al. Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau. BMJ 2006; 333:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/25\">",
"      Kabra SK, Lodha R, Hilton DJ. Antibiotics for preventing complications in children with measles. Cochrane Database Syst Rev 2008; :CD001477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/26\">",
"      Johnson RT, Griffin DE, Hirsch RL, et al. Measles encephalomyelitis--clinical and immunologic studies. N Engl J Med 1984; 310:137.",
"     </a>",
"    </li>",
"    <li>",
"     Adams RD, Victor M, Ropper AH. Multiple sclerosis and allied demyelinative diseases. In: Principles of Neurology, McGraw-Hill (Ed), New York City 1997. p.921.",
"    </li>",
"    <li>",
"     Dyken PR. Viral diseases of the central nervous system. In: Pediatric Neurology: Principles and Practice, Mosby, St. Louis 1994. p.670.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/29\">",
"      Centers for Disease Control (CDC). Subacute sclerosing panencephalitis surveillance - United States. MMWR Morb Mortal Wkly Rep 1982; 31:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/30\">",
"      Bellini WJ, Rota JS, Lowe LE, et al. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 2005; 192:1686.",
"     </a>",
"    </li>",
"    <li>",
"     Bernstein DI, Reuman PD, Schiff GM. Rubeola (measles) and subacute sclerosing panencephalitis virus. In: Infectious Diseases, Gorbach SL, Bartlett JG, Blacklow NR (Eds), WB Saunders, Philadelphia 1998. p.2135.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/32\">",
"      Garg RK. Subacute sclerosing panencephalitis. J Neurol 2008; 255:1861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/33\">",
"      Sun X, Burns JB, Howell JM, Fujinami RS. Suppression of antigen-specific T cell proliferation by measles virus infection: role of a soluble factor in suppression. Virology 1998; 246:24.",
"     </a>",
"    </li>",
"    <li>",
"     Adams RD, Victor M, Ropper AH. Viral infections of the central nervous system. In: Principles of Neurology, McGraw-Hill, New York City 1997. p.767.",
"    </li>",
"    <li>",
"     Fisch BJ. Periodic complexes. In: Spehlmann's EEG Primer, Fisch BJ (Ed), Elsevier Science, Amsterdam 1991. p.376.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/36\">",
"      Seo YS, Kim HS, Jung DE. 18F-FDG PET and MRS of the early stages of subacute sclerosing panencephalitis in a child with a normal initial MRI. Pediatr Radiol 2010; 40:1822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/37\">",
"      Kagame K, Schwab L. Childhood blindness: dateline Africa. Ophthalmic Surg 1989; 20:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/38\">",
"      Ross LA, Kim KS, Mason WH Jr, Gomperts E. Successful treatment of disseminated measles in a patient with acquired immunodeficiency syndrome: consideration of antiviral and passive immunotherapy. Am J Med 1990; 88:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/39\">",
"      Oldstone MB. Virus-lymphoid cell interactions. Proc Natl Acad Sci U S A 1996; 93:12756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/40\">",
"      Bhardwaj N. Interactions of viruses with dendritic cells: a double-edged sword. J Exp Med 1997; 186:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/41\">",
"      Kannangara S, DeSimone JA, Pomerantz RJ. Attenuation of HIV-1 infection by other microbial agents. J Infect Dis 2005; 192:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/42\">",
"      Moss WJ, Monze M, Ryon JJ, et al. Prospective study of measles in hospitalized, human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia. Clin Infect Dis 2002; 35:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/43\">",
"      Moss WJ, Ryon JJ, Monze M, et al. Suppression of human immunodeficiency virus replication during acute measles. J Infect Dis 2002; 185:1035.",
"     </a>",
"    </li>",
"    <li>",
"     Grivel J, Garca M, Moss W, et al. Chemokine/cytokine modulation by measles virus induces HIV-1 suppression in human lymphoid tissue ex vivo [abstract TuOrA1185]. In: EJournal of the International AIDS Society, XV International AIDS Conference (Bangkok). Geneva: International AIDS Society, 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/45\">",
"      Embree JE, Datta P, Stackiw W, et al. Increased risk of early measles in infants of human immunodeficiency virus type 1-seropositive mothers. J Infect Dis 1992; 165:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/46\">",
"      Scott S, Cumberland P, Shulman CE, et al. Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. J Infect Dis 2005; 191:1854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/47\">",
"      de Moraes-Pinto MI, Verhoeff F, Chimsuku L, et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed 1998; 79:F202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/48\">",
"      Atmar RL, Englund JA, Hammill H. Complications of measles during pregnancy. Clin Infect Dis 1992; 14:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/49\">",
"      Siegel M, Fuerst HT. Low birth weight and maternal virus diseases. A prospective study of rubella, measles, mumps, chickenpox, and hepatitis. JAMA 1966; 197:680.",
"     </a>",
"    </li>",
"    <li>",
"     Gershon AA. Chickenpox, measles and mumps. In: Infectious Diseases of the Fetus and Newborn Infant, 6th ed, Remington JS, Klein JO, Wilson CB, et al (Eds), Elsevier Saunders, Philadelphia 2006. p.693.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/51\">",
"      Siegel M, Fuerst HT, Peress NS. Comparative fetal mortality in maternal virus diseases. A prospective study on rubella, measles, mumps, chicken pox and hepatitis. N Engl J Med 1966; 274:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/52\">",
"      Bellini WJ, Helfand RF. The challenges and strategies for laboratory diagnosis of measles in an international setting. J Infect Dis 2003; 187 Suppl 1:S283.",
"     </a>",
"    </li>",
"    <li>",
"     Mason EO. Use of the serology laboratory. In: Textbook of Pediatric Infectious Diseases, 5th ed, Feigin RD, Cherry JD, Demmler GJ, et al (Eds), WB Saunders, Philadelphia 2004. p.3318.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/54\">",
"      Featherstone D, Brown D, Sanders R. Development of the Global Measles Laboratory Network. J Infect Dis 2003; 187 Suppl 1:S264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/11/43192/abstract/55\">",
"      Jenkerson SA, Beller M, Middaugh JP, Erdman DD. False positive rubeola IgM tests. N Engl J Med 1995; 332:1103.",
"     </a>",
"    </li>",
"    <li>",
"     Measles. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, Illinois 2012. p.444.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3021 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-69ABC6F150-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43192=[""].join("\n");
var outline_f42_11_43192=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Stages of infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Clinical variants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Modified measles",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Atypical measles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Pulmonary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Neurologic",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Encephalitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Acute disseminated encephalomyelitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Subacute sclerosing panencephalitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Eye manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Gastrointestinal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Cardiac",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      GROUPS AT RISK FOR COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Immunocompromised patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3021\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3021|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?40/6/41070\" title=\"picture 1\">",
"      Kopliks spots in measles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?4/26/4512\" title=\"picture 2A\">",
"      Truncal rash in measles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?6/12/6350\" title=\"picture 2B\">",
"      Boy with measles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?40/41/41618\" title=\"picture 3\">",
"      Measles pneumonia light microscopy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/52/25416?source=related_link\">",
"      Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/16/42246?source=related_link\">",
"      Epidemiology and transmission of measles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/56/2947?source=related_link\">",
"      Patient information: Measles (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22793?source=related_link\">",
"      Prevention and treatment of measles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/3/38968?source=related_link\">",
"      Viral encephalitis in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_11_43193="Aripiprazole: Drug information";
var content_f42_11_43193=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Aripiprazole: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?16/60/17350?source=see_link\">",
"    see \"Aripiprazole: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/35/7737?source=see_link\">",
"    see \"Aripiprazole: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708627\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F136801\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Abilify Discmelt&reg;;",
"     </li>",
"     <li>",
"      Abilify Maintena&trade;;",
"     </li>",
"     <li>",
"      Abilify&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9490633\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Abilify&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F136821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antipsychotic Agent, Atypical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F136805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Oral solution may be substituted for the oral tablet on a mg-per-mg basis, up to 25 mg. Patients receiving 30 mg tablets should be given 25 mg oral solution. Orally disintegrating tablets (Abilify Discmelt&reg;) are bioequivalent to the immediate release tablets (Abilify&reg;).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Acute agitation (schizophrenia/bipolar mania):",
"     </b>",
"     I.M.: 9.75 mg as a single dose (range: 5.25-15 mg); repeated doses may be given at  &ge;2-hour intervals to a maximum of 30 mg/day.",
"     <b>",
"      Note:",
"     </b>",
"     If ongoing therapy with aripiprazole is necessary, transition to oral therapy as soon as possible.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Bipolar I disorder (acute manic or mixed episodes):",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Stabilization:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Monotherapy: Initial: 15 mg once daily. May increase to 30 mg once daily if clinically indicated; safety of doses &gt;30 mg/day has not been evaluated",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adjunct to lithium or valproic acid: Initial: 10-15 mg once daily.  May increase to 30 mg once daily if clinically indicated; safety of doses &gt;30 mg/day has not been evaluated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Maintenance:",
"     </i>",
"     Continue stabilization dose for up to 6 weeks; efficacy of continued treatment &gt;6 weeks has not been established.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Depression (adjunctive with antidepressants):",
"     </b>",
"     Oral: Initial: 2-5 mg/day (range: 2-15 mg/day); dose adjustments of up to 5 mg/day may be made in intervals of &ge;1 week.",
"     <b>",
"      Note:",
"     </b>",
"     Dosing based on patients already receiving antidepressant therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Schizophrenia:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Oral: 10-15 mg once daily; may be increased to a maximum of 30 mg once daily (efficacy at dosages above 10-15 mg has not been shown to be increased). Dosage titration should not be more frequent than every 2 weeks.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M, extended release (Abilify Maintena&trade;): 400 mg once monthly (doses should be separated by &ge;26 days);",
"     <b>",
"      Note:",
"     </b>",
"     Tolerability should be established using oral aripiprazole prior to initiation of parenteral therapy. Continue oral aripiprazole (or other oral antipsychotic) for 14 days during initiation of parenteral therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Missed doses:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:2em;margin-left:4em;text-align:justify;\">",
"     Second or third doses missed:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     &gt;4 weeks but &lt;5 weeks since last dose: Administer next dose as soon as possible",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     &gt;5 weeks since last dose: Administer oral aripiprazole for 14 days with next injection",
"    </p>",
"    <p style=\"text-indent:2em;margin-left:4em;text-align:justify;\">",
"     Fourth or subsequent doses missed:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     &gt;4 weeks but &lt;6 weeks since last dose: Administer next dose as soon as possible",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     &gt;6 weeks since last dose: Administer oral aripiprazole for 14 days with next injection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Dosage adjustment for adverse effects:",
"     </i>",
"     Consider reducing dose to 300 mg once monthly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment with concurrent CYP450 inducer or inhibitor therapy:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CYP3A4 inducers (eg, carbamazepine): Aripiprazole dose should be doubled; dose should be subsequently reduced if concurrent inducer agent discontinued.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Strong CYP3A4 inhibitors (eg, ketoconazole): Aripiprazole dose should be reduced to 50% of the usual dose, and proportionally increased upon discontinuation of the inhibitor agent.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Strong CYP2D6 inhibitors (eg, fluoxetine, paroxetine): Aripiprazole dose should be reduced to 50% of the usual dose, and proportionally increased upon discontinuation of the inhibitor agent.",
"     <b>",
"      Note:",
"     </b>",
"     Dose reduction does not apply to patients with major depressive disorder; follow usual dosing recommendations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CYP3A4 and CYP2D6 inhibitors: Aripiprazole dose should be reduced to 25% of the usual dose. In patients receiving inhibitors of differing (eg, moderate 3A4/strong 2D6) or same (eg, moderate 3A4/moderate 2D6) potencies (excluding concurrent strong inhibitors), further dosage adjustments can be made to achieve the desired clinical response. In patients receiving strong CYP3A4 and 2D6 inhibitors, aripiprazole dose is proportionally increased upon discontinuation of one or both inhibitor agents.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     I.M., extended release (Abilify Maintena&trade;): Note: Dosage adjustments are not recommended for concomitant use of CYP3A4 inhibitors, CYP2D6 inhibitors or CYP3A4 inducers for &lt;14 days.  In patients who had their aripiprazole dose adjusted for concomitant therapy, the aripiprazole dose may need to be increased if the CYP3A4 and/or CYP2D6 inhibitor is withdrawn.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     CYP3A4 inducers: Avoid use; aripiprazole serum concentrations may fall below effective levels.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Strong CYP3A4 or CYP2D6 inhibitors:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;text-align:justify;\">",
"     Current aripiprazole dose of 300 mg once monthly: Reduce aripiprazole dose to 200 mg once monthly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;text-align:justify;\">",
"     Current aripiprazole dose of 400 mg once monthly: Reduce aripiprazole dose to 300 mg once monthly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Strong CYP3A4 inhibitors",
"     <b>",
"      and",
"     </b>",
"     CYPD2D6 inhibitors:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;text-align:justify;\">",
"     Current aripiprazole dose of 300 mg once monthly: Reduce aripiprazole dose to 160 mg once monthly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;text-align:justify;\">",
"     Current aripiprazole dose of 400 mg once monthly: Reduce aripiprazole dose to 200 mg once monthly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment based on CYP2D6 metabolizer status:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Oral: Aripiprazole dose should be reduced to 50% of the usual dose in CYP2D6 poor metabolizers and to 25% of the usual dose in poor metabolizers receiving a concurrent strong CYP3A4 inhibitor; subsequently adjust dose for favorable clinical response.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     I.M., extended release (Abilify Maintena&trade;): Reduce aripiprazole dose to 300 mg once monthly in CYP2D6 poor metabolizers; reduce dose to 200 mg once monthly in CYP2D6 poor metabolizers receiving a concurrent CYP3A4 inhibitor for &gt;14 days.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F3362491\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/35/7737?source=see_link\">",
"      see \"Aripiprazole: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Oral solution may be substituted for the oral tablet on a mg-per-mg basis, up to 25 mg. Patients receiving 30 mg tablets should be given 25 mg oral solution. Orally disintegrating tablets (Abilify Discmelt&reg;) are bioequivalent to the immediate release tablets (Abilify&reg;).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Bipolar I disorder (acute manic or mixed episodes):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      U.S. labeling:",
"     </i>",
"     Children &ge;10 years: Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Stabilization: Initial: 2 mg once daily for 2 days, followed by 5 mg once daily for 2 days with a further increase to target dose of 10 mg once daily as monotherapy or as adjunct to lithium or valproic acid; subsequent dose increases may be made in 5 mg increments, up to a maximum of 30 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Maintenance: Continue stabilization dose for up to 6 weeks; efficacy of continued treatment &gt;6 weeks has not been established.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Canadian labeling:",
"     </i>",
"     Adolescents &ge;13 years: Oral: Initial: 2 mg once daily for 2 days, followed by 5 mg once daily for 2 days with a further increase to target dose of 10 mg once daily as monotherapy;  subsequent dose increases may be made in 5 mg increments, up to a maximum of 30 mg/day.",
"     <b>",
"      Note:",
"     </b>",
"     Not approved for maintenance or as adjunctive therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Irritability associated with autistic disorder:",
"     </b>",
"     Children &ge;6 years: Oral: Initial: 2 mg once daily for 7 days, followed by an increase to 5 mg once daily; subsequent dose increases may be made in 5 mg increments at intervals of &ge;1 week as needed, up to a maximum of 15 mg/day. Efficacy of continued treatment &gt;8 weeks has not been established; the need for ongoing treatment should be assessed periodically.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Schizophrenia:",
"     </b>",
"     Adolescents &ge;13 years (U.S. labeling) or &ge;15 years (Canadian labeling):  Oral: Initial: 2 mg once daily for 2 days, followed by 5 mg once daily for 2 days with a further increase to target dose of 10 mg once daily; subsequent dose increases may be made in 5 mg increments up to a maximum of 30 mg/day (30 mg/day not shown to be more efficacious than 10 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment with concurrent CYP450 inducer or inhibitor therapy, or adjustment based on CYP2D6 metabolizer status:",
"     </b>",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F136806\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F136807\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F136808\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F136774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for suspension, extended release:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Abilify Maintena&trade;: 300 mg, 400 mg [supplied with diluent]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Abilify&reg;: 7.5 mg/mL (1.3 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Abilify&reg;: 1 mg/mL (150 mL) [contains fructose 200 mg/mL, propylene glycol, sucrose 400 mg/mL; orange cream flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Abilify&reg;: 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, 30 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, orally disintegrating, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Abilify Discmelt&reg;: 10 mg [contains phenylalanine 1.12 mg/tablet; creme de vanilla flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Abilify Discmelt&reg;: 15 mg [contains phenylalanine 1.68 mg/tablet; creme de vanilla flavor]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F136761\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F16321186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     Abilify Maintena: FDA approved March 2013; availability anticipated in March 2013.  Consult prescribing information for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874282\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and as follows, must be dispensed with this medication:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Abilify&reg;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/ucm085804.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/ucm085804.pdf",
"     </a>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Abilify Maintena&trade;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM342207.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM342207.pdf",
"     </a>",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F136778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection: For I.M. use only; do not administer SubQ or I.V.;",
"     <b>",
"      Note:",
"     </b>",
"     Immediate release and extended release parenteral products are",
"     <b>",
"      not",
"     </b>",
"     interchangeable.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Immediate release (Abilify&reg;): Inject slowly into deep muscle mass",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Extended release (Abilify Maintena&trade;): Inject slowly into gluteal muscle using the provided 1.5 inch (38 mm) needle for nonobese patients or the provided 2 inch (50 mm) needle for obese patients. Do not massage muscle after administration. Rotate injection sites between the two gluteal muscles. Administer monthly (doses should be separated by &ge;26 days).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: May be administered with or without food. Tablet and oral solution may be interchanged on a mg-per-mg basis, up to 25 mg. Doses using 30 mg tablets should be exchanged for 25 mg oral solution. Orally disintegrating tablets (Abilify Discmelt&reg;) are bioequivalent to the immediate release tablets (Abilify&reg;).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Orally disintegrating tablet: Remove from foil blister by peeling back (do not push tablet through the foil). Place tablet in mouth immediately upon removal. Tablet dissolves rapidly in saliva and may be swallowed without liquid. If needed, can be taken with liquid. Do not split tablet.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F136777\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Acute and maintenance treatment of schizophrenia; acute (manic and mixed episodes) and maintenance treatment of bipolar I disorder as monotherapy or as an adjunct to lithium or valproic acid; adjunctive treatment of major depressive disorder; treatment of irritability associated with autistic disorder",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection: Agitation associated with schizophrenia or bipolar I disorder (Abilify&reg;); treatment of schizophrenia (Abilify Maintena&trade;)",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F136817\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Depression with psychotic features; aggression (children); conduct disorder (children); Tourette syndrome (children); pervasive developmental disorder not otherwise specified (PDD-NOS) (children);  Asperger's Disorder (children); psychosis/agitation related to Alzheimer's dementia",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F136828\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Abilify&reg; may be confused with Ambien&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       ARIPiprazole may be confused with proton pump inhibitors (dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole, RABEprazole)",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       There are two formulations available for intramuscular administration: Abilify&reg; is an immediate release short-acting formulation and Abilify Maintena&trade; is an extended-release formulation. These products are",
"       <b>",
"        not",
"       </b>",
"       interchangeable.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F4049888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Unless otherwise noted, frequency of adverse reactions is shown as reported for adult patients receiving oral administration. Spectrum and incidence of adverse effects similar in children; exceptions noted when incidence much higher in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (27%; injection 12%), agitation (19%), insomnia (18%), anxiety (17%), EPS (dose related; 5% to 16%; children 6% to 26%), akathisia (dose related; 8% to 13%; injection 2%), sedation (dose related; 5% to 11%; children 8% to 24%; injection 3% to 9%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Weight gain (2% to 30%; highest frequency in patients with baseline BMI &lt;23 and prolonged use), nausea (15%; injection 9%), constipation (11%), vomiting (11%; children 9% to 14%; injection 3%), dyspepsia (9%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Orthostatic hypotension (1% to 4%; injection 1% to 3%), tachycardia (injection 2%), chest pain, hypertension, peripheral edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Dizziness (10%; injection 8%), pyrexia (children 5% to 9%), restlessness (5% to 6%), fatigue (dose related; 6%; children 8% to 17%; injection 2%), lethargy (children 2% to 5%), lightheadedness (4%), pain (3%), dystonia (children 1%), hypersomnia (1%), irritability (children 1%), coordination impaired, suicidal ideation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (children 2%), hyperhidrosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Dysmenorrhea (children 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Salivation increased (dose related; children 4% to 9%), appetite decreased (children 4% to 7%), appetite increased (children 7%), xerostomia (5%), toothache (4%), abdominal discomfort (3%), diarrhea (children 5%), weight loss",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection site reaction (injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Tremor (dose related; 5% to 6%; children 6% to 10%), extremity pain (4%), stiffness (4%), myalgia (2%), spasm (2%), arthralgia (children 1%), dyskinesia (children 1%), CPK increased, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Blurred vision (3%; children 3% to 8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Nasopharyngitis (children 6%), pharyngolaryngeal pain (3%), cough (3%), rhinorrhea (children 2%), aspiration pneumonia, dyspnea, nasal congestion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Thirst (children 1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Aggression, agranulocytosis, alopecia, akinesia, amenorrhea, anaphylactic reaction, anger, angina pectoris, angioedema, anorexia, anorgasmia, atrial fibrillation, atrial flutter, atrioventricular block, bilirubin increased, bradycardia, bradykinesia, breast pain, cardiopulmonary failure, cardiorespiratory arrest, catatonia, cerebrovascular accident, choreoathetosis, cogwheel rigidity, creatinine increased, delirium, diplopia, diabetes mellitus, DKA, dysphagia, edema (facial), erectile dysfunction, esophagitis, extrasystoles, GGT increased, glycosylated hemoglobin increased, gynecomastia, heat stroke, hepatic enzyme increased, hepatitis, homicidal ideation, hostility, hyper-/hypoglycemia, hyper-/hypotonia, hyperlipidemia, hypersensitivity, hypokalemia, hypokinesia, hyponatremia, hypotension, hypothermia, intentional self injury, jaundice, lactate dehydrogenase increased, leukopenia, libido changes, memory impairment, menstrual irregularities, MI, muscle rigidity, myocardial ischemia, myoclonus, neutropenia, nocturia, oropharyngeal spasm, palpitation, pancreatitis, parkinsonism, photophobia, polydypsia, polyuria, priapism, prolactin increased, pruritus, QT",
"     <sub>",
"      c",
"     </sub>",
"     prolonged, rhabdomyolysis, seizure (grand mal), speech disorder, suicide, suicide attempt, supraventricular tachycardia, swollen tongue, syncope, tardive dyskinesia, thrombocytopenia, tic, urea increased, urinary retention, urticaria, ventricular tachycardia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F136781\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to aripiprazole or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F136764\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Major psychiatric warnings:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Suicidal thinking/behavior:",
"     <b>",
"      [U.S. Boxed Warning]: Antidepressants increase the risk of suicidal thinking and behavior in children, adolescents, and young adults (18-24 years of age) with major depressive disorder (MDD) and other psychiatric disorders;",
"     </b>",
"     consider risk prior to prescribing. Short-term studies did not show an increased risk in patients &gt;24 years of age and showed a decreased risk in patients &ge;65 years. Closely monitor patients for clinical worsening, suicidality, or unusual changes in behavior, particularly during the initial 1-2 months of therapy or during periods of dosage adjustments (increases or decreases); the patient&rsquo;s family or caregiver should be instructed to closely observe the patient and communicate condition with healthcare provider. A medication guide concerning the use of antidepressants should be dispensed with each prescription.",
"     <b>",
"      Aripiprazole is not FDA approved for adjunctive treatment of depression in children.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; The possibility of a suicide attempt is inherent in major depression and may persist until remission occurs. Patients treated with antidepressants should be observed for clinical worsening and suicidality, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases. Worsening depression and severe abrupt suicidality that are not part of the presenting symptoms may require discontinuation or modification of drug therapy. Use caution in high-risk patients during initiation of therapy. Patients should be screened for bipolar disorder prior to initiation of treatment of major depression.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prescriptions should be written for the smallest quantity consistent with good patient care. The patient's family or caregiver should be alerted to monitor patients for the emergence of suicidality and associated behaviors such as anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, akathisia, hypomania, and mania; patients should be instructed to notify their healthcare provider if any of these symptoms or worsening depression or psychosis occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse reactions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Altered cardiac conduction: May alter cardiac conduction; life-threatening arrhythmias have occurred with therapeutic doses of antipsychotics.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Blood dyscrasias: Leukopenia, neutropenia, and agranulocytosis (sometimes fatal) have been reported in clinical trials and postmarketing reports with antipsychotic use; presence of risk factors (eg, pre-existing low WBC or history of drug-induced leuko-/neutropenia) should prompt periodic blood count assessment. Discontinue therapy at first signs of blood dyscrasias or if absolute neutrophil count &lt;1000/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cerebrovascular effects: An increased incidence of cerebrovascular effects (eg, transient ischemic attack, stroke), including fatalities, has been reported in placebo-controlled trials of aripiprazole for the unapproved use in elderly patients with dementia-related psychosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dyslipidemia: Has been reported with atypical antipsychotics; risk profile may differ between agents. In clinical trials, lipid changes observed with aripiprazole monotherapy were similar to those observed with placebo.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Esophageal dysmotility/aspiration: Antipsychotic use has been associated with esophageal dysmotility and aspiration; use with caution in patients at risk of pneumonia (eg, Alzheimer's disease).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Extrapyramidal symptoms (EPS): May cause extrapyramidal symptoms, including pseudoparkinsonism, acute dystonic reactions, akathisia, and tardive dyskinesia (risk of these reactions is generally much lower relative to typical/conventional antipsychotics; frequencies reported are similar to placebo). Risk of dystonia (and probably other EPS) may be greater with increased doses, use of conventional antipsychotics, males, and younger patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperglycemia: Atypical antipsychotics have been associated with development of hyperglycemia; in some cases, may be extreme and associated with ketoacidosis, hyperosmolar coma, or death. Use with caution in patients with diabetes or other disorders of glucose regulation; monitor for worsening of glucose control. Reports of hyperglycemia with aripiprazole therapy have been few and specific risk associated with this agent is not known.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neuroleptic malignant syndrome (NMS): Use may  be associated with neuroleptic malignant syndrome (NMS); monitor for mental status changes, fever, muscle rigidity and/or autonomic instability.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Orthostatic hypotension: May cause orthostatic hypotension; use with caution in patients at risk of this effect or in those who would not tolerate transient hypotensive episodes (cerebrovascular disease, cardiovascular disease, hypovolemia, or concurrent medication use which may predispose to hypotension/bradycardia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedation: May be sedating, use with caution in disorders where CNS depression is a feature; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Temperature regulation: Impaired core body temperature regulation may occur; caution with strenuous exercise, heat exposure, dehydration, and concomitant medication possessing anticholinergic effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Weight gain: Significant weight gain has been observed with antipsychotic therapy; incidence varies with product. Monitor waist circumference and BMI.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with cardiac disease, cerebrovascular disease, prior myocardial infarction, ischemic heart disease,  or conditions which predispose to hypotension.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dementia:",
"     <b>",
"      [U.S. Boxed Warning]: Elderly patients with dementia-related psychosis treated with antipsychotics are at an increased risk of death compared to placebo.",
"     </b>",
"     Most deaths appeared to be either cardiovascular (eg, heart failure, sudden death) or infectious (eg, pneumonia) in nature.  Aripiprazole is not approved for the treatment of dementia-related psychosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Parkinson's disease: Use with caution in patients with Parkinson's disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizures: Use with caution in patients at risk of seizures, including those with a history of seizures, head trauma, brain damage, alcoholism, or concurrent therapy with medications which may lower seizure threshold. Elderly patients may be at increased risk of seizures due to an increased prevalence of predisposing factors.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use in patients with dementia is associated with an increased risk of mortality and cerebrovascular accidents; avoid antipsychotic use for behavioral problems associated with dementia unless alternative nonpharmacologic therapies have failed and patient may harm self or others. In addition, use may cause or exacerbate syndrome of inappropriate antidiuretic hormone secretion or hyponatremia; monitor sodium closely with initiation or dosage adjustments in older adults (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Lactose: Tablets contain lactose; avoid use in patients with galactose intolerance or glucose-galactose malabsorption.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Phenylalanine: Abilify Discmelt&reg; contains phenylalanine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Product interchangeability: There are two formulations available for intramuscular administration: Abilify&reg; is an immediate release short-acting formulation and Abilify Maintena&trade; is an extended-release formulation. These products are",
"     <b>",
"      not",
"     </b>",
"     interchangeable.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F136814\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2D6 (major), CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F136768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP2D6 Substrates. Management: Avoid concurrent use of abiraterone with CYP2D6 substrates that have a narrow therapeutic index whenever possible.  When concurrent use is not avoidable, monitor patients closely for signs/symptoms of toxicity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): May enhance the neurotoxic (central) effect of Antipsychotics. Severe extrapyramidal symptoms have occurred in some patients.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Antipsychotics may diminish the stimulatory effect of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anti-Parkinson's Agents (Dopamine Agonist): Antipsychotics (Atypical) may diminish the therapeutic effect of Anti-Parkinson's Agents (Dopamine Agonist).  Management: Consider using an alternative antipsychotic agent when possible in patients with Parkinson's disease.  If an atypical antipsychotic is necessary, consider using clozapine or quetiapine, which may convey the lowest interaction risk.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Moderate): May increase the serum concentration of ARIPiprazole. Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Strong): May increase the serum concentration of ARIPiprazole. Management: See full interaction monograph for details.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Weak): May increase the serum concentration of ARIPiprazole. Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers: May decrease the serum concentration of ARIPiprazole. Management: Double the oral aripiprazole dose and closely monitor clinical response.  Reduce the oral aripiprazole dose to 10-15 mg/day if the inducer is discontinued. Avoid use of CYP3A4 inducers for more than 14 days with extended-release injectable aripiprazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May increase the serum concentration of ARIPiprazole. Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May increase the serum concentration of ARIPiprazole. Management: See full interaction monograph for details.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Weak): May increase the serum concentration of ARIPiprazole. Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DULoxetine: ARIPiprazole may enhance the adverse/toxic effect of DULoxetine. ARIPiprazole may enhance the serotonergic effect of DULoxetine. This could result in serotonin syndrome. DULoxetine may increase the serum concentration of ARIPiprazole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FLUoxetine: May enhance the adverse/toxic effect of ARIPiprazole. Specifically, the risk of risk of neuroleptic malignant syndrome may be increased. ARIPiprazole may enhance the serotonergic effect of FLUoxetine. This could result in serotonin syndrome. FLUoxetine may increase the serum concentration of ARIPiprazole. Management: Aripiprazole dose should be reduced by at least half, except when used adjunctively for depression. Consult full interaction monograph or aripiprazole prescribing information for complete details.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.  Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium formulations: May enhance the neurotoxic effect of Antipsychotics. Lithium formulations may decrease the serum concentration of Antipsychotics. Specifically noted with chlorpromazine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: Antipsychotics may enhance the adverse/toxic effect of Methylphenidate. Methylphenidate may enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying). Management: Though the drugs listed here have uncertain QT-prolonging effects, they all have some possible association with QT prolongation and should generally be avoided when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PARoxetine: May enhance the adverse/toxic effect of ARIPiprazole. Specifically, the risk of risk of neuroleptic malignant syndrome may be increased. ARIPiprazole may enhance the serotonergic effect of PARoxetine. This could result in serotonin syndrome. PARoxetine may increase the serum concentration of ARIPiprazole. Management: Aripiprazole dose adjustment is recommended, except when used adjunctively for depression. Consult full interaction monograph or aripiprazole prescribing information for complete details.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinagolide: Antipsychotics may diminish the therapeutic effect of Quinagolide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: Antipsychotics may enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetrabenazine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F136798\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Ingestion with a high-fat meal delays time to peak plasma level.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: St John's wort may decrease aripiprazole levels. Avoid kava kava, gotu kola, valerian, St John's wort (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F136770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F136784\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Aripiprazole demonstrated developmental toxicity and teratogenic effects in animal models. Antipsychotic use during the third trimester of pregnancy has a risk for abnormal muscle movements (extrapyramidal symptoms [EPS]) and withdrawal symptoms in newborns following delivery. Symptoms in the newborn may include agitation, feeding disorder, hypertonia, hypotonia, respiratory distress, somnolence, and tremor; these effects may be self-limiting or require hospitalization. Information specific to the use of aripiprazole in pregnancy is limited. Treatment algorithms have been developed by the ACOG and the APA for the management of depression in women prior to conception and during pregnancy (Yonkers, 2009).  Healthcare providers are encouraged to enroll women 18-45 years of age exposed to aripiprazole during pregnancy in the Atypical Antipsychotics Pregnancy Registry (866-961-2388 or file://www.womensmentalhealth.org/pregnancyregistry).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F136812\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F11401964\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Aripiprazole is excreted in breast milk. According to the manufacturer, the decision to continue or discontinue breast-feeding during therapy should take into account the risk of exposure to the infant and the benefits of treatment to the mother.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F136786\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken with or without food. Some products may contain phenylalanine.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F136783\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Abilify Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     9.75 mg/1.3 mL (1.3 mL): $23.65",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Abilify Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 mg/mL (150 mL): $833.70",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension (reconstituted)",
"     </b>",
"     (Abilify Maintena Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     300 mg (1): $1305.60",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     400 mg (1): $1740.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, orally-disintegrating",
"     </b>",
"     (Abilify Discmelt Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (30): $901.72",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15 mg (30): $901.72",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Abilify Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 mg (30): $757.61",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (30): $757.61",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (30): $757.61",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15 mg (30): $757.61",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (30): $1071.35",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30 mg (30): $1071.35",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F136772\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Vital signs; fasting lipid profile and fasting blood glucose/Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     (prior to treatment, at 3 months, then annually); CBC frequently during first few months of therapy in patients with pre-existing low WBC or a history of drug-induced leukopenia/neutropenia; BMI, personal/family history of diabetes, waist circumference, blood pressure, mental status, abnormal involuntary movement scale (AIMS), extrapyramidal symptoms (EPS). Weight should be assessed prior to treatment, at 4 weeks, 8 weeks, 12 weeks, and then at quarterly intervals. Consider titrating to a different antipsychotic agent for a weight gain &ge;5% of the initial weight.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5539821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Abilify (AT, AU, BE, BG, BR, CH, CL, CN, CO, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HK, HN, ID, IE, IL, IT, KP, MT, MX, MY, NL, NO, PH, PL, PT, RU, SE, SG, SK, TH, TR, VE, ZA);",
"     </li>",
"     <li>",
"      Abilify Discmelt (PH);",
"     </li>",
"     <li>",
"      Abilify ODT (NZ);",
"     </li>",
"     <li>",
"      Arika (TW);",
"     </li>",
"     <li>",
"      Ariple (TW);",
"     </li>",
"     <li>",
"      Ariprazol (GT, PA);",
"     </li>",
"     <li>",
"      Arive (IN);",
"     </li>",
"     <li>",
"      Arizol (UY);",
"     </li>",
"     <li>",
"      Arizole (TW);",
"     </li>",
"     <li>",
"      Arlemide (AR);",
"     </li>",
"     <li>",
"      Azymol (PE);",
"     </li>",
"     <li>",
"      Brisking (CL);",
"     </li>",
"     <li>",
"      Ilimit (PE, UY);",
"     </li>",
"     <li>",
"      Irazem (AR);",
"     </li>",
"     <li>",
"      Zedan (PK)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F136763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Aripiprazole is a quinolinone antipsychotic which exhibits high affinity for D",
"     <sub>",
"      2",
"     </sub>",
"     , D",
"     <sub>",
"      3",
"     </sub>",
"     , 5-HT",
"     <sub>",
"      1A",
"     </sub>",
"     , and 5-HT",
"     <sub>",
"      2A",
"     </sub>",
"     receptors; moderate affinity for D",
"     <sub>",
"      4",
"     </sub>",
"     , 5-HT",
"     <sub>",
"      2C",
"     </sub>",
"     , 5-HT",
"     <sub>",
"      7",
"     </sub>",
"     , alpha",
"     <sub>",
"      1",
"     </sub>",
"     adrenergic, and H",
"     <sub>",
"      1",
"     </sub>",
"     receptors. It also possesses moderate affinity for the serotonin reuptake transporter; has no affinity for muscarinic (cholinergic) receptors. Aripiprazole functions as a partial agonist at the D",
"     <sub>",
"      2",
"     </sub>",
"     and 5-HT",
"     <sub>",
"      1A",
"     </sub>",
"     receptors, and as an antagonist at the 5-HT",
"     <sub>",
"      2A",
"     </sub>",
"     receptor.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F136780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Initial: 1-3 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 4.9 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: &ge;99%, primarily to albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic, via CYP2D6, CYP3A4 (dehydro-aripiprazole metabolite has affinity for D",
"     <sub>",
"      2",
"     </sub>",
"     receptors similar to the parent drug and represents 40% of the parent drug exposure in plasma)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: I.M.: 100%; Tablet: 87%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Aripiprazole: 75 hours; dehydro-aripiprazole: 94 hours; I.M., extended release (terminal): ~30-47 days (dose-dependent)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CYP2D6 poor metabolizers:  Aripiprazole: 146 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Immediate release: 1-3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Extended release: 5-7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tablet: 3-5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     With high-fat meal: Aripiprazole: Delayed by 3 hours; dehydro-aripiprazole: Delayed by 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Feces (55%, ~18% of the total dose as unchanged drug); urine (25%, &lt;1% of the total dose as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity, &ldquo;Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes,&rdquo;",
"      <i>",
"       Diabetes Care",
"      </i>",
"      , 2004, 27(2):596-601.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/14747245/pubmed\" id=\"14747245\" target=\"_blank\">",
"        14747245",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Barbee JG, Conrad EJ, and Jamhour NJ,  &ldquo;Aripiprazole Augmentation in Treatment-Resistant Depression,&rdquo;",
"      <i>",
"       Ann Clin Psychiatry",
"      </i>",
"      , 2004, 16(4):189-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/15702566/pubmed\" id=\"15702566\" target=\"_blank\">",
"        15702566",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Barzman DH, DelBello MP, Kowatch RA, et al  &ldquo;The Effectiveness and Tolerability of Aripiprazole for Pediatric Bipolar Disorders: A Retrospective Chart Review,&rdquo;",
"      <i>",
"       J Child Adolesc Psychopharmacol",
"      </i>",
"      , 2004, 14(4):593-600.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/15662152/pubmed\" id=\"15662152\" target=\"_blank\">",
"        15662152",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bastiaens L, \"A Non-Randomized, Open Study With Aripiprazole and Ziprasidone for the Treatment of Aggressive Behavior in Youth in a Community Clinic,\"",
"      <i>",
"       Community Ment Health J",
"      </i>",
"      , 2009, 45(1):73-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/18597173/pubmed\" id=\"18597173\" target=\"_blank\">",
"        18597173",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Biederman J, McDonnell MA, Wozniak, et al, &ldquo;Aripiprazole in the Treatment of Pediatric Bipolar Disorder: A Systematic Chart Review,&rdquo;",
"      <i>",
"       CNS Spectr",
"      </i>",
"      , 2005, 10(2):141-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/15685125/pubmed\" id=\"15685125\" target=\"_blank\">",
"        15685125",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Burris KD, Molski TF, Xu C, et al, &ldquo;Aripiprazole, A Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors,&rdquo;",
"      <i>",
"       J Pharmacol Exp Ther",
"      </i>",
"      , 2002, 302(1):381-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/12065741/pubmed\" id=\"12065741\" target=\"_blank\">",
"        12065741",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Davis JM, Chen N, and Glick ID, &ldquo;A Meta-Analysis of the Efficacy of Second-Generation Antipsychotics,&rdquo;",
"      <i>",
"       Arch Gen Psychiatry",
"      </i>",
"      , 2003, 60(6):553-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/12796218/pubmed\" id=\"12796218\" target=\"_blank\">",
"        12796218",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dixon L, Perkins D, and Calmes C,",
"      <i>",
"       Guideline Watch (September 2009): Practice Guideline for the Treatment of Schizophrenia",
"      </i>",
"      , Arlington, Va: American Psychiatric Association, 2009. Available at  file://www.psychiatryonline.com/content.aspx?aid=501001",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Duane DD, &ldquo;Aripiprazole in Childhood and Adolescence for Tourette Syndrome,&rdquo;",
"      <i>",
"       J Child Neurol",
"      </i>",
"      , 2006, 21(4):358.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/16900939/pubmed\" id=\"16900939\" target=\"_blank\">",
"        16900939",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Durkin JP, &ldquo;Aripiprazole in the Treatment of Bipolar Disorder in Children and Adolescents,&rdquo;",
"      <i>",
"       J Child Adolesc Psychopharmacol",
"      </i>",
"      , 2004, 14(4):505-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/15662141/pubmed\" id=\"15662141\" target=\"_blank\">",
"        15662141",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Findling RL, Kauffman R, Sallee FR, et al, \"An Open-Label Study of Aripiprazole: Pharmacokinetics, Tolerability, and Effectiveness in Children and Adolescents With Conduct Disorder,\"",
"      <i>",
"       J Child Adolesc Psychopharmacol",
"      </i>",
"      , 2009, 19(4):431-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/19702495/pubmed\" id=\"19702495\" target=\"_blank\">",
"        19702495",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gill SS, Bronskill SE, Normand SL, et al, &ldquo;Antipsychotic Drug Use and Mortality in Older Adults With Dementia,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2007, 146(11):775-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/17548409/pubmed\" id=\"17548409\" target=\"_blank\">",
"        17548409",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hellerstein DJ, &ldquo;Aripiprazole as an Adjunctive Treatment for Refractory Major Depression,&rdquo;",
"      <i>",
"       Prog Neuropsychopharmacol Biol Psychiatry",
"      </i>",
"      , 2004, 28(8):1347-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/15588762/pubmed\" id=\"15588762\" target=\"_blank\">",
"        15588762",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Inoue A, Miki S, Seto M, et al, &ldquo;Aripiprazole, A Novel Antipsychotic Drug, Inhibits Quinpirole-Evoked GTPase Activity But Does Not Up-Regulate Dopamine D2 Receptor Following Repeated Treatment in the Rat Striatal Slices,&rdquo;",
"      <i>",
"       Eur J Pharmacol",
"      </i>",
"      , 1997, 321(1):105-11.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/9083792/pubmed\" id=\"9083792\" target=\"_blank\">",
"        9083792",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jordan S, Koprivica V, Chen R, et al, &ldquo;The Antipsychotic Aripiprazole Is a Potent, Partial Agonist at the Human 5-HT(1A) Receptor,&rdquo;",
"      <i>",
"       Eur J Pharmacol",
"      </i>",
"      , 2002, 441(3):137-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/12063084/pubmed\" id=\"12063084\" target=\"_blank\">",
"        12063084",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kane JM, Carson WH, Saha AR, et al, &ldquo;Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 2002, 63(9):763-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/12363115/pubmed\" id=\"12363115\" target=\"_blank\">",
"        12363115",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ketter TA, Wang PW, Chandler RA, et al, &ldquo;Adjunctive Aripiprazole in Treatment-Resistant Bipolar Depression,&rdquo;",
"      <i>",
"       Ann Clin Psychiatry",
"      </i>",
"      , 2006, 18(3):169-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/16923655/pubmed\" id=\"16923655\" target=\"_blank\">",
"        16923655",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lawler CP, Prioleau C, Lewis MM, et al, &ldquo;Interactions of the Novel Antipsychotic Aripiprazole (OPC-14597) With Dopamine and Serotonin Receptor Subtypes,&rdquo;",
"      <i>",
"       Neuropsychopharmacology",
"      </i>",
"      , 1999, 20(6):612-27.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/10327430/pubmed\" id=\"10327430\" target=\"_blank\">",
"        10327430",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lutz UC, Hiemke C, Wiatr G, et al, &ldquo;Aripiprazole in Pregnancy and Lactation: A Case Report,&rdquo;",
"      <i>",
"       J Clin Psychopharmacol",
"      </i>",
"      , 2010. 30(2):204-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/20520299/pubmed\" id=\"20520299\" target=\"_blank\">",
"        20520299",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Matsubayashi H, Amano T, and Sasa M, &ldquo;Inhibition by Aripiprazole of Dopaminergic Inputs to Striatal Neurons From Substantia Nigra,&rdquo;",
"      <i>",
"       Psychopharmacology",
"      </i>",
"      (Berl), 1999, 146(2):139-43.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McGavin JK and Goa KL, &ldquo;Aripiprazole,&rdquo;",
"      <i>",
"       CNS Drugs",
"      </i>",
"      , 2002, 16(11):779-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/12383035/pubmed\" id=\"12383035\" target=\"_blank\">",
"        12383035",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mendhekar DN, Sunder KR, and Andrade C, &ldquo;Aripiprazole Use in a Pregnant Schizoaffective Woman,&rdquo;",
"      <i>",
"       Bipolar Disord",
"      </i>",
"      , 2006, 8(3):299-300.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/16696834/pubmed\" id=\"16696834\" target=\"_blank\">",
"        16696834",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mervak B, Collins J, and Valenstein M, &ldquo;Case Report of Aripiprazole Usage During Pregnancy,&rdquo;",
"      <i>",
"       Arch Womens Ment Health",
"      </i>",
"      , 2008, 11(3):249-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/18581041/pubmed\" id=\"18581041\" target=\"_blank\">",
"        18581041",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moore TA, &ldquo;Schizophrenia Treatment Guidelines in the United States,&rdquo;",
"      <i>",
"       Clin Schizophr Relat Psychoses",
"      </i>",
"      , 2011, 5(1):40-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/21459738/pubmed\" id=\"21459738\" target=\"_blank\">",
"        21459738",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Health and Clinical Excellence (NICE), National Collaborating Centre for Mental Health , &ldquo;Schizophrenia. Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Updated),&rdquo; National Clinical Practice Guideline Number 82, 2009:1-399. Available at  www.nice.org.uk/cg082",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Papakostas GI, Petersen TJ, Kinrys G, et al, &ldquo;Aripiprazole Augmentation of Selective Serotonin Reuptake Inhibitors for Treatment-Resistant Major Depressive Disorder,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 2005, 66(10):1326-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/16259548/pubmed\" id=\"16259548\" target=\"_blank\">",
"        16259548",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Patkar AA, Peindl K, Mago R, et al,  &ldquo;An Open-Label, Rater-Blinded, Augmentation Study of Aripiprazole in Treatment-Resistant Depression,&rdquo;",
"      <i>",
"       Prim Care Companion J Clin Psychiatry",
"      </i>",
"      , 2006, 8(2):82-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/16862232/pubmed\" id=\"16862232\" target=\"_blank\">",
"        16862232",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rabins PV, Blacker D, Rovner BW, et al, &ldquo;American Psychiatric Association Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias. Second Edition,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 2007, 164(12 Suppl):5-56.  Available at file://psychiatryonline.org/guidelines.aspx",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/18340692/pubmed\" id=\"18340692\" target=\"_blank\">",
"        18340692",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rugino TA and Janvier YM, &ldquo;Aripiprazole in Children And Adolescents: Clinical Experience,&rdquo;",
"      <i>",
"       J Child Neurol",
"      </i>",
"      , 2005, 20(7):603-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/16159529/pubmed\" id=\"16159529\" target=\"_blank\">",
"        16159529",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schneeweiss S, Setoguchi S, Brookhart A, et al, &ldquo;Risk of Death Associated With the Use of Conventional Versus Atypical Antipsychotic Drugs Among Elderly Patients,&rdquo;",
"      <i>",
"       CMAJ",
"      </i>",
"      , 2007, 176(5): 627-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/17325327/pubmed\" id=\"17325327\" target=\"_blank\">",
"        17325327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schlotterbeck P, Leube D, Kircher T, et al, &ldquo;Aripiprazole in Human Milk,&rdquo;",
"      <i>",
"       Int J Neuropsychopharmacol",
"      </i>",
"      , 2007, 10(3):433.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/17291382/pubmed\" id=\"17291382\" target=\"_blank\">",
"        17291382",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schneider LS, Tariot PN, Dagerman KS, et al, &ldquo;Effectiveness of Atypical Antipsychotic Drugs in Patients With Alzheimer's Disease,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2006, 355(15):1525-38.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/17035647/pubmed\" id=\"17035647\" target=\"_blank\">",
"        17035647",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Simon JS and Nemeroff CB, &ldquo;Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 2005, 66(10):1216-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/16259533/pubmed\" id=\"16259533\" target=\"_blank\">",
"        16259533",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stigler KA, Posey DJ, and McDougle CJ, &ldquo;Aripiprazole for Maladaptive Behavior in Pervasive Developmental Disorders,&rdquo;",
"      <i>",
"       J Child Adolesc Psychopharmacol",
"      </i>",
"      , 2004,  14(3):455-63.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/15650503/pubmed\" id=\"15650503\" target=\"_blank\">",
"        15650503",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Suppes T, Dennehy EB, Hirschfeld RMA, et al, &ldquo;The Texas Implementation of Medication Algorithms: Update to the Algorithms for the Treatment of Bipolar I Disorder,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 2005, 66(7):870-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/16013903/pubmed\" id=\"16013903\" target=\"_blank\">",
"        16013903",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Worthington JJ 3rd, Kinrys G, Wygant LE, et al, &ldquo;Aripiprazole as an Augmentor of Selective Serotonin Reuptake Inhibitors in Depression and Anxiety Disorder Patients,&rdquo;",
"      <i>",
"       Int Clin Psychopharmacol",
"      </i>",
"      , 2005, 20(1):9-11.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/15602109/pubmed\" id=\"15602109\" target=\"_blank\">",
"        15602109",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yonkers KA, Wisner KL, Stewart DE, et al, &ldquo;The Management of Depression During Pregnancy: A Report From the American Psychiatric Association and the American College of Obstetricians and Gynecologists,&rdquo;",
"      <i>",
"       Obstet Gynecol",
"      </i>",
"      , 2009, 114(3):703-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/19701065/pubmed\" id=\"19701065\" target=\"_blank\">",
"        19701065",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yoo HK, Kim JY, Kim CY.  &ldquo;A Pilot Study of Aripiprazole in Children and Adolescents With Tourette's Disorder,&rdquo;",
"      <i>",
"       J Child Adolesc Psychopharmacol",
"      </i>",
"      , 2006, 16(4):505-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/16958578/pubmed\" id=\"16958578\" target=\"_blank\">",
"        16958578",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yoo HK, Lee JS, Paik KW, et al, &ldquo;Open-label Study Comparing the Efficacy and Tolerability of Aripiprazole and Haloperidol in the Treatment of Pediatric Tic Disorders,&rdquo;",
"      <i>",
"       Eur Child Adolesc Psychiatry",
"      </i>",
"      , 2011, 20(3):127-35.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/11/43193/abstract-text/21188439/pubmed\" id=\"21188439\" target=\"_blank\">",
"        21188439",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8786 Version 46.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-9E6425AB09-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43193=[""].join("\n");
var outline_f42_11_43193=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708627\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136801\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9490633\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136821\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136805\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3362491\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136806\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136807\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136808\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136774\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136761\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16321186\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874282\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136778\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136777\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136817\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136828\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4049888\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136781\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136764\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136814\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136768\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136798\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136770\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136784\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136812\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11401964\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136786\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136783\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136772\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5539821\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136763\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136780\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8786\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8786|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?16/60/17350?source=related_link\">",
"      Aripiprazole: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/35/7737?source=related_link\">",
"      Aripiprazole: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_11_43194="Basic case 2";
var content_f42_11_43194=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63895&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63895&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1212px;\">",
"  <div class=\"figure\" style=\"width: 498px\">",
"   <div class=\"ttl\">",
"    Basic case 2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 478px; height: 293px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43194=[""].join("\n");
var outline_f42_11_43194=null;
var title_f42_11_43195="Chemotherapy acral erythema";
var content_f42_11_43195=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F78089&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F78089&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Conventional cytotoxic chemotherapy agents causing  hand-foot skin reaction (HFSR)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Bleomycin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Capecitabine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cisplatin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cyclophosphamide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cytarabine*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Daunorubicin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Docetaxel",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Doxifluridine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Doxorubicin (particularly the liposomal preparation)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Etoposide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fludarabine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fluorouracil (infusional regimens)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gemcitabine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydroxyurea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Idarubicin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ixabepilone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methotrexate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mitotane",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Paclitaxel",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tegafur",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thiotepa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vinorelbine",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Particularly in patients receiving cytarabine plus an anthracycline for treatment of acute leukemia.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Susser WS, et al. Mucucutaneous reactions to chemotherapy. J Am Acad Dermatol 1999; 40:367, and Alley E, et al. Cutaneous toxicities of cancer therapy. Curr Opin Oncol 2002; 14:212; and Escudier B, et al. N Engl J Med 2007; 356:125; and Hoff PM, et al. Cancer 1998; 82:965.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43195=[""].join("\n");
var outline_f42_11_43195=null;
var title_f42_11_43196="Causes LV outflow obstruction";
var content_f42_11_43196=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F51024&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F51024&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Distinguishing characteristics of the causes of left ventricular outflow tract obstruction",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"5\" width=\"20%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Valvular",
"       </td>",
"       <td class=\"subtitle1\">",
"        Supravalvular",
"       </td>",
"       <td class=\"subtitle1\">",
"        Discrete subvalvular",
"       </td>",
"       <td class=\"subtitle1\">",
"        Obstructive hypertrophic cardiomyopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Pulse pressure after ventricular premature beat",
"        </strong>",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"       <td>",
"        Decreased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Valsalva effect on systolic murmur",
"        </strong>",
"       </td>",
"       <td>",
"        Decreased",
"       </td>",
"       <td>",
"        Decreased",
"       </td>",
"       <td>",
"        Decreased",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Murmur of aortic regurgitation",
"        </strong>",
"       </td>",
"       <td>",
"        Common after age 40",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Sometimes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Fourth heart sound (S4)",
"        </strong>",
"       </td>",
"       <td>",
"        If severe",
"       </td>",
"       <td>",
"        Uncommon",
"       </td>",
"       <td>",
"        Uncommon",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Paradoxic splitting",
"        </strong>",
"       </td>",
"       <td>",
"        Sometimes*",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Common*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Ejection click",
"        </strong>",
"       </td>",
"       <td>",
"        Most (unless valve calcified)",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Uncommon or none",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Maximal thrill and murmur",
"        </strong>",
"       </td>",
"       <td>",
"        Second RIS",
"       </td>",
"       <td>",
"        <p>",
"         First RIS",
"        </p>",
"        Suprasternal notch",
"       </td>",
"       <td>",
"        Second RIS",
"       </td>",
"       <td>",
"        Fourth LIS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Carotid pulse",
"        </strong>",
"       </td>",
"       <td>",
"        Normal to anacrotic* (parvus et tardus)",
"       </td>",
"       <td>",
"        Unequal",
"       </td>",
"       <td>",
"        Normal to anacrotic",
"       </td>",
"       <td>",
"        Brisk, jerky, systolic rebound",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Valve calcification",
"        </strong>",
"       </td>",
"       <td>",
"        Common after age 40",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Dilated ascending aorta",
"        </strong>",
"       </td>",
"       <td>",
"        Common after age 40",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LIS: left intercostal space; RIS: right intercostal space.",
"     <br/>",
"     * Depends upon severity.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol 2006; 48:e1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43196=[""].join("\n");
var outline_f42_11_43196=null;
var title_f42_11_43197="Progestin effect on BMD 2";
var content_f42_11_43197=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61971&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61971&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 570px\">",
"   <div class=\"ttl\">",
"    BMD during/after DMPA use in adult women",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 550px; height: 345px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Scholes, D, LaCroix, AZ, Ichikawa, LE, et al. Injectable hormone contraception and bone density: results from a prospective study. Epidemiology 2002; 13:581. Copyright &copy;2002 Lippincott Williams and Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43197=[""].join("\n");
var outline_f42_11_43197=null;
var title_f42_11_43198="Contents: Gram negative rods";
var content_f42_11_43198=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?15/21/15710\">",
"       Infectious Diseases",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Gram negative rods",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Gram negative rods",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Acinetobacter",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/49/14103\">",
"           Epidemiology, microbiology and pathogenesis of Acinetobacter infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/54/23402\">",
"           Treatment and prevention of Acinetobacter infection",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Aeromonas/Plesiomonas",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/24/23943\">",
"           Aeromonas infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/30/4582\">",
"           Plesiomonas shigelloides infections",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Bacteremia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/12/20681\">",
"           Gram-negative bacillary bacteremia in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Brucella",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/43/16058\">",
"           Clinical manifestations, diagnosis, and treatment of brucellosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/61/33751\">",
"           Microbiology, epidemiology, and pathogenesis of Brucella",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Campylobacter",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/19/19769\">",
"           Clinical manifestations, diagnosis, and treatment of Campylobacter infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/58/19368\">",
"           Infection with less common Campylobacter species and related bacteria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/60/5065\">",
"           Microbiology, pathogenesis, and epidemiology of Campylobacter infection",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Escherichia coli",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/57/14232\">",
"           Clinical manifestations, diagnosis and treatment of enterohemorrhagic Escherichia coli (EHEC) infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/19/18745\">",
"           Microbiology, pathogenesis, epidemiology, and prevention of enterohemorrhagic Escherichia coli (EHEC)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/4/37960\">",
"           Pathogenic Escherichia coli",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Francisella tularensis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/10/30888\">",
"           Clinical manifestations, diagnosis, and treatment of tularemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/53/14166\">",
"           Epidemiology, microbiology, and pathogenesis of tularemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Haemophilus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/40/41608\">",
"           Microbiology, epidemiology and treatment of Haemophilus influenzae",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Klebsiella",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/33/38426\">",
"           Clinical features, diagnosis, and treatment of Klebsiella pneumoniae infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/31/29176\">",
"           Invasive liver abscess syndrome caused by Klebsiella pneumoniae",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/18/21801\">",
"           Microbiology and pathogenesis of Klebsiella pneumoniae infection",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Legionella",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/19/38199\">",
"           Clinical manifestations and diagnosis of Legionella infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/58/32680\">",
"           Epidemiology and pathogenesis of Legionella infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/15/33015\">",
"           Treatment and prevention of Legionella infection",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pasteurella",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/0/13321\">",
"           Pasteurella infections",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pseudomonas",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/32/27145\">",
"           Epidemiology and pathogenesis of Pseudomonas aeruginosa infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/41/39577\">",
"           Epidemiology, pathogenesis, clinical manifestations, and diagnosis of melioidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/47/32503\">",
"           Other Pseudomonas aeruginosa infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/48/31494\">",
"           Pseudomonas aeruginosa pneumonia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/8/43142\">",
"           Pseudomonas aeruginosa skin, soft tissue, and bone infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/48/34567\">",
"           Treatment and prognosis of melioidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/38/39528\">",
"           Treatment of Pseudomonas aeruginosa infections",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Salmonella",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/8/26761\">",
"           Approach to the patient with nontyphoidal Salmonella in a stool culture",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/2/42024\">",
"           Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/19/14649\">",
"           Microbiology and epidemiology of salmonellosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/51/31542\">",
"           Nontyphoidal Salmonella bacteremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/37/19033\">",
"           Pathogenesis of Salmonella gastroenteritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/6/21607\">",
"           Pathogenesis of typhoid fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/58/18345\">",
"           Treatment and prevention of typhoid fever",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Shigella",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/40/38535\">",
"           Clinical manifestations and diagnosis of Shigella infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/1/42008\">",
"           Epidemiology, microbiology, and pathogenesis of Shigella infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/26/39334\">",
"           Treatment and prevention of Shigella infection in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Stenotrophomonas",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/60/8135\">",
"           Stenotrophomonas maltophilia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Vibrio",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/4/18502\">",
"           Infections due to non-O1/O139 Vibrio cholerae",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/31/504\">",
"           Minor Vibrio and Vibrio-like species associated with human disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/14/36073\">",
"           Overview of Vibrio cholerae infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/4/29768\">",
"           Pathogenesis of Vibrio cholerae infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/14/27878\">",
"           Vibrio parahaemolyticus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/42/44710\">",
"           Vibrio vulnificus infections",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Yersinia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/63/41974\">",
"           Clinical manifestations and diagnosis of Yersinia infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/15/11512\">",
"           Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/21/31062\">",
"           Epidemiology of yersiniosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/12/24774\">",
"           Epidemiology, microbiology and pathogenesis of plague (Yersinia pestis infection)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/54/22373\">",
"           Microbiology and pathogenesis of Yersinia infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/7/32885\">",
"           Treatment and prevention of Yersinia enterocolitica and Yersinia pseudotuberculosis infection",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-C20EDE2636-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f42_11_43198=[""].join("\n");
var outline_f42_11_43198=null;
var title_f42_11_43199="Hepatic adenomas CT";
var content_f42_11_43199=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66984&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66984&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hepatic adenomas",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 284px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A CT scan of the liver demonstrates two complex masses in the liver. Adenomas are usually solitary tumors. Multiple adenomas are commonly present in patients with glycogen storage disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_11_43199=[""].join("\n");
var outline_f42_11_43199=null;
